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ABSTRACT
BOK SOON GO. Glutamatergic Neurotransmission in the Prefrontal Cortex
Mediates the Suppressive Effect of Intra-PFC Infusion of BDNF on CocaineSeeking (Under the direction of JACQUELINE F. MCGINTY)
Infusion of BDNF into the dorsomedial prefrontal cortex (dmPFC) immediately
after the last session of cocaine self-administration prevents cocaine-mediated
malfunction of synaptic modulation in the dmPFC that mediates relapse to
cocaine-seeking through both GluN2A subunit-containing NMDA receptors and
GluN2B subunit-containing NMDA receptors (NMDARS). Intra-dmPFC BDNF is
known to suppress cocaine-seeking by normalization of cocaine selfadministration-induced disturbance of glutamatergic transmission in the nucleus
accumbens (NAc) and by prevention of the cocaine self-administration-induced
decrease in extracellular signal-regulated kinase (ERK) activity in the dmPFC
through activation of tyrosine receptor kinase B (TrkB). Neuronal activity is
required for BDNF-induced ERK activation and the interaction between TrkB
receptors and synaptic NMDA receptors upregulates ERK activity. The current
study found that infusion of a mixture of the AMPA receptor antagonist, CNQX,
and the NMDA receptor antagonist, LY235959, (CNQX/LY235959), the GluN2Acontaining NMDA receptor antagonist, TCN-201, or the GluN2B-containing
NMDA receptor antagonist, Ro-25-6981, into the dmPFC of rats immediately
after the final session of cocaine self-administration inhibited BDNF’s

ix

suppressive effect on cocaine-seeking during a context-induced relapse test after
home-cage abstinence and during a conditioned cue-induced reinstatement test.
We also found that during early withdrawal from cocaine self-administration,
intra-dmPFC BDNF infusion prevented cocaine self-administration-induced
reduction of phosphorylated ERK, GluN2A (Y1325) and GluN2B (Y1472) levels
in the dmPFC. TCN-201 infusion into the dmPFC blocked the BDNF-mediated
increase in pGluN2A (Y1325) and Ro-25-6981 infusion into the dmPFC
suppressed the BDNF-induced elevation of pGluN2B (Y1472) expression and
both

GluN2

antagonists

blocked

BDNF-mediated

ERK

phosphorylation,

indicating that both GluN2A- and GluN2B-containing NMDA receptors mediate
BDNF-mediated ERK phosphorylation. Together, these findings indicate that
BDNF-mediated co-activation of GluN2A- or GluN2B-containing NMDA receptors
induces ERK activation in the dmPFC, which prevents relapse to cocaineseeking.

x

CHAPTER1

INTRODUCTION

Drug addiction is a chronic disease showing persistent drug-seeking and taking
despite its harmful effects and currently there is no cure. Cocaine is one of the
most prevalent illegal drugs causing addiction. Cocaine is a strong central
nervous psychostimulant that induces a feeling of euphoria at initial stages by
activating brain regions involved in pleasure and reinforcement. However, during
withdrawal or abstinence, this rewarding effect of cocaine is replaced by a
negative emotional state that includes dysphoria, anxiety and depression. To
avoid the negative withdrawal syndrome and to recover the reinforcing effect,
people continuously use increasing amounts of cocaine, which results in
persistent neuroadaptations in the reward pathways of brain, leading to
development of chronic relapse even after prolonged abstinence which is a
crucial feature of cocaine addiction. Neuroscience researchers have investigated
the neural circuitries that are responsible for cocaine addiction in order to
develop effective treatment approaches. However, despite these advances, there
is no cure approved for cocaine addiction. Therefore, research on the molecular
mechanisms underlying cocaine-mediated neuroadaptaions will enhance the
1

potential molecular targets for the treatment of cocaine addiction, which would
facilitate therapeutic development for cocaine addicts. Further, neurobiological
research could expand the therapeutic possibilities available to addicted
individuals depending on their phase or severity of addiction as well as provide
more cost-effective and safe options for treatment.
REVIEW OF RELEVANT LITERATURE
Cocaine induces neural adaptations in the PFC-NAc glutamatergic pathway
associated with cocaine-seeking
Drug addiction is a brain disease characterized by chronic relapse to drugseeking and use, which is mediated by long-lasting alteration of neuroplasticity in
reward circuits (White and Kalivas, 2001; Koob and Volkow, 2010; Weiss et al.,
2001; Kalivas and Volkow, 2005). The mesocorticolimbic dopaminergic pathway
which arises from the ventral tegmental area (VTA) and projects to prefrontal
cortex (PFC) and the nucleus accumbens (NAc) is the circuitry associated with
drug-mediated reward and motivation. Cocaine acts on this mesocorticolimbic
system as an indirect dopamine agonist by increasing synaptic dopaminergic
concentrations (van Huijstee and Mansvelder, 2015). Cocaine-induced increase
in dopamine transmission in the dorsal medial (dm) PFC but not in the NAc core
drives cocaine-seeking in rats with cocaine self-administration (SA) history. After
extinction training, infusion of the D1/D2 antagonist fluphenazine into the dmPFC,
but not into the NA core, suppresses systemic cocaine prime-induced cocaineseeking in rats with a cocaine SA history, suggesting that the dopaminergic
pathway from the VTA to the dmPFC but not from VTA to the NA core is involved
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in cocaine-seeking behavior (McFarland and Kalivas, 2001). Glutamatergic rather
than dopaminergic neurotransmission in the NAc core contributes to cocaine
prime-induced reinstatement. Although dopamine infusion into the NAc core
induces reinstatement of cocaine-seeking after extinction training, intra-NAc core
infusion of the dopamine receptor antagonist, fluphenazine, inhibits the
reinstatement induced by intra-NAc core dopamine only, but infusion of the
AMPA/kainate receptor antagonist, CNQX, into the NAc core blocks the
reinstatement of cocaine-seeking mediated by intra-NAc core dopamine,
systemic injection of cocaine, and intra-NAc core AMPA, respectively (Cornish
and Kalivas, 2000). Moreover, infusion of the AMPA/KA receptor antagonist,
LY293558, into the NAc core also suppresses cue-induced cocaine-seeking (Di
Ciano and Everitt, 2001). The NAc core is densely innervated by glutamatergic
axons of pyramidal cells in the dmPFC and glutamatergic neurotransmission in
the dmPFC to NAc core pathway underlies reinstatement of cocaine-seeking
after extinction by cocaine-conditioned context, cue, or cocaine-prime (Fuchs et
al., 2005; McLaughlin and See, 2003; Park et al., 2002; McFarland et al., 2003).
Cocaine-seeking induced by systemic cocaine injection following cocaine SA
selectively enhances extracellular levels of glutamate but not dopamine in the rat
NAc core and this cocaine-seeking behavior was suppressed by blockade of
neuronal activity in dmPFC, suggesting that the glutamatergic pathway from the
dmPFC to NAC core underlies this cocaine-seeking (McFarland et al., 2003).
Both brain derived neurotrophic factor (BDNF), an important modulator of
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neurotransmission and neural plasticity, and its receptor tyrosine kinase B (TrkB)
are highly expressed in the dmPFC-NAc core neurons (Altar et al., 1997).
BDNF modulates synaptic plasticity and neurotransmission
While proBDNF (immature form) preferentially binds to the p75 (NTR), mature
BDNF preferentially acts on TrkB receptors, and mature BDNF has an ability to
promote neurotransmission. In the adult rat hippocampus, TrkB is expressed at
both the presynaptic and postsynaptic regions of synapses (Drake et al., 1999),
and the presynaptic TrkB may underlie BDNF-mediated enhancement of
neurotransmitter release. In postnatal cortical neurons, BDNF increases
glutamate release via PLC gamma and ERK, both of which are downstream
components of TrkB signaling (Matsumoto et al., 2006). In addition, BDNF
promotes neuronal activity-induced glutamate release from nerve terminals of rat
and mouse cerebral cortices via ERK-mediated phosphorylation of synapsin I
(Jovanovic et al., 2000).
BDNF binding to TrkB activates TrkB’s tyrosine kinase activity, triggering
the phosphorylation and activation of downstream signaling cascades, including
mitogen-activated extracellular signal-regulated kinase (ERK), phosphoinositol 3kinase (PI3K), and phospholipase C gamma PLCγ1 (Huang and Reichardt, 2003;
Reichardt, 2006), leading to gene transcription via activation of cyclic AMP
response element binding protein (CREB) (Finkbeiner et al., 1997). BDNFmediated CREB activation may contribute to long-term neural plasticity through
new protein expression required for the maintenance of synaptic plasticity during
4

extended periods. BDNF induces both the early and late phases of LTP in the
hippocampus. BDNF/TrkB signaling induces the early phase of LTP by releasing
existing presynaptic BDNF contents and modulation of existing proteins located
at presynaptic and postsynaptic regions, but the late phases of LTP require
BDNF-mediated new protein synthesis (Waterhouse and Xu, 2009). Therefore,
dysregulation of BDNF/TrkB signaling and subsequent CREB activity may lead to
long-lasting neural adaptations associated with persistent behavioral changes.
BDNF/TrkB signaling in the dmPFC and NAc core is associated with
cocaine-seeking
Cocaine-mediated long-lasting dysregulation of synaptic function and structures
in the reward circuit underlie the chronic relapse to cocaine-seeking. A previous
study from our laboratory found that cocaine SA induces dephosphorylation and
inactivation of ERK and CREB during early withdrawal in the rat dmPFC, and this
cocaine-mediated dephosphorylation was inhibited by intra-dmPFC BDNF when
infused immediately after the last session of cocaine SA via Trk receptor-ERK
signaling in the dmPFC (Whitfield et al., 2011). In addition, cocaine SA induces
reduction of BDNF mRNA 22 h after the last session of cocaine SA (McGinty et
al., 2010). Cocaine-induced prefrontal hypoactivity during withdrawal may be
linked to the cocaine-mediated reduction of BDNF/TrkB signaling in the dmPFC.
In rats with a cocaine SA history, the basal activity of the dmPFC is suppressed
(Sun and Rebec, 2006) and human cocaine addicts show suppressed basal
levels of activity in the PFC (Bolla et al., 2004; Volkow et al., 1992; Volkow and
Fowler, 2000), Neuronal activity upregulates BDNF expression in the cerebral
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cortex and TrkB surface expression in cultured hippocampal neurons (Poo, 2001).
Together, this supports the assumption that a cocaine-mediated decrease in
BDNF/TrkB signaling in the dmPFC is due to hypofrontality. Berglind and
colleagues (2009) previously showed that BDNF infusion into the dmPFC
immediately after the last cocaine SA session normalized a cocaine-mediated
disturbance in glutamatergic transmission in the NAc core and this BDNF
infusion

also

decreased

reinstatement of

cocaine-seeking

triggered by

conditioned stimuli (CS), context, or cocaine (Berglind et al., 2007; Whitfield et al.,
2011). Inhibition of BDNF-TrkB signaling in the NAc core before cocaine SA
increases cue-induced cocaine seeking after 1d withdrawal from cocaine SA,
suggesting basal levels of BDNF in the NAc core contributes to the suppression
of cocaine seeking during early withdrawal (Li et al., 2013). Together, cocainemediated alterations of BDNF/TrkB signaling in the dmPFC and NAc core may
underlie enduring relapse to cocaine-seeking.
NMDA receptors mediates long-term neuroplasticity and has a functional
role in cocaine-seeking
The postsynaptic calcium influx through NMDA receptors plays an essential role
in long-lasting synaptic plasticity like long-term potentiation (LTP) and long-term
depression (LTD) (Kauer and Malenka, 2007; Lau and Zukin 2007). NMDARs are
tetrameric assemblies of two obligatory GluN1 subunits and two modulatory
GluN2 (A-D) or GluN3 (A-B) subunits and both GluN2A and GluN2B subunits
show higher expression in the cerebral cortex compared to other modulatory
subunits (Lau and Zukin 2007; Yashiro and Philpot, 2008). Both GluN2A and
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GluN2B subunits of NMDARs are involved in the induction of LTP and LTD
(Yashiro and Philpot, 2008; Sakimura et al., 1995; Miwa et al., 2008; Brigman et
al., 2000). In the rat PFC, NMDAR stimulation induces long-term potentiation
(LTP) and long-term depression (LTD) in vitro (Hirsch and Crepel, 1990). In
addition, NMDAR induces LTP in the rat hippocampal-prefrontal cortex pathway
in vivo (Jay et al., 1995). Dopamine (DA) also modulates rat PFC long-term
plasticity, LTP and LTD (Otani et al., 2003). D1 but not D2 receptors in the rat
PFC mediate LTP induction at hippocampal-prefrontal synapses (Gurden et al.,
2000). Together, as cocaine acts as an indirect dopamine agonist in the dmPFC,
these results suggest that cocaine may induce long-term synaptic plasticity in the
dmPFC via DA receptors and/or through crosstalk between DA receptors and
NMDARS. This dysregulation of neural plasticity in the dmPFC may also affect
the synaptic plasticity in the NAc core through modulation of the dmPFC-NAc
pathway. During withdrawal from cocaine SA, the ability to mediate LTP and LTD
is compromised in the rat NAc core (Moussawi et al., 2009), which supports this
idea. As cocaine addiction is characterized by its inability to adapt behavior in
response to new stimuli associated with the persistent cocaine-seeking after
extended periods of abstinence, this malfunctioning neural plasticity of the
essential brain regions of dmPFC and NAc core in cocaine addiction may
underlie cocaine-mediated long-lasting neuroadaptations linked to enduring
relapse to cocaine-seeking.
There is also ample evidence indicating the role of NMDAR in the
regulation of cocaine-seeking behaviors using NMDAR agonist/antagonists. A
7

partial NMDA receptor agonist, D-cycloserine (DCS), has been found to facilitate
the extinction of conditioned place preference (CPP) of cocaine in rats (Botreau
et al., 2006, Yang et al., 2013). In rats with a cocaine SA history, DCS also
facilitates the extinction of cocaine-seeking and reduces reacquisition of cocaine
SA (Thanos et al., 2011; Nic Dhonnchadha et al., 2010). In parallel with this,
while an NMDA receptor antagonist CPP decreases the suppressive effect of
extinction training on cocaine-primed reinstatement of cocaine seeking
(Kelamangalath et al., 2007), d-serine, the NMDAR co-agonist, suppresses
cocaine-primed reinstatement following extinction in rats with short and long
access coc-SA history, respectively (Kelamangalath et al., 2009; Kelamangalath
and Wagner, 2010). Together, as both BDNF and NMDARs are involved in
synaptic plasticity as well as cocaine-seeking, finding a plausible relationship
between TrkB and NMDARs in reward-related brain regions would expand our
understanding of the mechanism underlying the roles of BDNF/TrkB signaling
and NMDARs in cocaine addiction.
Interaction between BDNF/TrkB signaling and NMDA receptor function and
its effect on ERK activity
Both BDNF and TrkB are highly expressed in the PFC and striatum (McGinty et
al., 2010). In the adult rat cerebral cortex, TrkB and BDNF are localized
discretely in postsynaptic densities (PSD) of excitatory glutamatergic synapses
(Aoki et al., 2000) and BDNF can be anterogradely transported to excitatory axon
terminals and released in subcortical targets like the NAc core (Altar et al., 1997)
in an activity-dependent manner (Balkowiec and Katz, 2002, McGinty et al.,
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2010). In cortical cultures, glutamatergic neuronal activity is involved in the
maintenance of BDNF-mediated ERK activity and for BDNF-induced potentiation
of glutamate transmission (Matsumoto et al., 2006). Both TrkB and synaptic
NMDARs are involved in the upregulation of ERK activity. NMDARs have
opposite roles in the regulation of ERK activity. While synaptic NMDARs upregulate ERK activity, extrasynaptic NMDARs down-regulate it (Ivanov et al.,
2006). GluN2A-containing NMDARs and GluN2B-containing NMDARs are
localized in both the synaptic and extrasynaptic regions (Thomas et al. 2006).
TrkB receptors are localized in postsynaptic densities (PSD) of excitatory
glutamatergic synapses in the adult rat cerebral cortex (Aoki et al., 2000). In
dissociated cultures of cortical neurons, the co-localization between the GluN1
and TrkB on the cellular surface is increased at glutamatergic synapses during
development (Gomes et al., 2006).
GluN2A

(Y1325)

and

GluN2B

(Y1472)

are

the

major

tyrosine

phosphorylation sites targeted by the Src family non-receptor tyrosine kinases
(SFK), including Src and Fyn (Chen and Roche, 2007; Goebel-Goody et al.,
2009), and phosphorylation of these sites positively modulates the function of
NMDARs. In Fyn-mutant mice, tyrosine phosphorylation of GluN2A was
decreased, and Fyn increases its tyrosine phosphorylation in cultured human
embryonic kidney 293T cells (Tezuka et al., 1999). In cells transfected with
GluN1 and GluN2A subunits, Src and Fyn promote the amplitude of glutamateactivated whole-cell currents through phosphorylation of tyrosines in the Cterminal domain of GluN2A without affecting the desensitization and deactivation
9

kinetics (Kohr and Seeburg 1996), and the Y1325 residue of GluN2A is located
within the C-terminal domain (Zheng et al., 1998). In cultured PFC neurons,
activation of D1 receptors increases GluN2B expression in the cellular
membrane through Fyn kinase (Hu et al., 2010). In cultured postnatal rat PFC
pyramidal neurons, phosphorylation of GluN2B (Y1472) increases surface
expression of GluN2B (Gao and Wolf, 2008). Fyn and Src phosphorylate GluN2B
(Y1472), leading to an increase in GluN2B synaptic expression (Nakazawa et al.,
2001; Cheung and Gurd, 2001; Goebel-Goody et al., 2009). Together, SFKmediated upregulation of synaptic GluN2A-contatining NMDARs and GluN2Bcontatining NMDARs may contribute to ERK activity.
BDNF/TrkB can increase the functions of synaptic GluN2A-contatining
NMDARs or GluN2B-contatining NMDARs through SFK activation. In the PSD of
rat cerebral cortex, BDNF mediates phosphorylation of GluN2B (Y1472) via Trk
receptors, SFK, ERK or PI3K (Xu et al., 2006). Activation of TrkB facilitates the
association of TrkB with Src or Fyn (Huang and McNamara, 2010; Iwasaki et al.,
1998). BDNF stimulation mediates Fyn activity (Narisawa-Saito et al., 1999) and
tyrosine phosphorylation of GluN2B in the cortical PSD fraction of rats (Lin et al.,
1998). BDNF increases single NMDA receptor channel activity through Fyn
activation (Xu et al., 2006). Binding of SFK to PSD is required for the tyrosine
phosphorylation of GluN2A or GluN2B subunits by Fyn or Src (Cheung and Gurd,
2001), suggesting that SFK-mediated phosphorylation of both GluN2 subunits
preferentially occurs at the synaptic region. In the supraoptic nucleus of the rat,
water deprivation promotes TrkB phosphorylation at Y515 and also the physical
10

interaction of TrKB with Fyn or with GluN2B. Phosphorylation of GluN2B at
Y1472 is also increased after water deprivation in a TrkB-dependent way
(Carreño et al., 2011). This suggests the role of TrkB activity in the association of
TrkB-Fyn-GluN2B and TrkB-mediated phosphorylation of GluN2B at Y1472 via
Fyn. BDNF also increases the total protein levels of the GluN1, GluN2A and
GluN2B subunits in a Trk receptor-dependent way through up-regulation of
mRNA levels of the GluN1, GluN2A and GluN2B in hippocampal neuronal
cultures of rat (Caldeira et al., 2007). Inhibition of the GluN2B-containing NMDAR
decreases the BDNF-mediated increase in the amplitude of glutamate-induced
synaptic currents in hippocampal neurons, suggesting that BDNF-induced
activation of GluN2B-containing NMDAR in the synaptic region underlies this
effect of BDNF (Crozier et al., 1999).
Together, BDNF/TrkB/SFK-induced phosphorylation and upregulation of
GluN2A- or GluN2B-containing NMDAR at the synaptic region may contribute to
BDNF-induced ERK activity.
PURPOSE OF THE STUDY
Intra-dmPFC BDNF infusion immediately after the final session of cocaine SA
decreased reinstatement of cocaine-seeking induced by conditioned stimuli (CS)
or cocaine in a TrkB-ERK dependent way (Berglind et al., 2007; Whitfield et al.,
2011). BDNF infusion into the dmPFC immediately after the last cocaine SA
session

normalized

a

cocaine-mediated

disturbance

in

glutamatergic

transmission in the NAc core associated with suppression of cocaine-seeking
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(Berglind et al., 2009). In cortical cultures, glutamatergic neuronal activity is
involved in the maintenance of BDNF-mediated ERK activity and for BDNFinduced potentiation of glutamate transmission (Matsumoto et al., 2006). To
assess the involvement of synaptic activity in the dmPFC on the BDNF-mediated
suppression of cocaine-seeking, immediately after the final session of cocaine
SA, we infused a mixture of AMPAR/NMDAR antagonists (CNQX/LY235959)
before BDNF to inhibit BDNF’s suppression on cocaine-seeking during a postabstinence relapse test after 6d of home-cage abstinence and a cue-induced
reinstatement test after extinction. As the decreased phosphorylation of GluN2B,
but not AMPAR subunit GluA1, was found during early withdrawal from short
access cocaine SA, (Sun et al., 2013), after we examined the essential role of
synaptic activity in BDNF’s suppressive effects, we hypothesized more
specifically that NMDAR activity may underlie the suppressive ability of intradmPFC BDNF on cocaine-seeking. To examine the role of modulatory GluN2
subunits in BDNF‘s suppressive effect on cocaine-seeking, the dmPFC of a
separate group of rats was infused with the GluN2A-selective antagonist, TCN201, or the GluN2B-selective antagonist, Ro-25-6981, 20 min before BDNF
immediately after the final session of cocaine SA. Then, we hypothesized that
GluN2A-contatining NMDARs or GluN2B-contatining NMDARs may underlie
BDNF-induced phosphorylation of ERK in the dmPFC. To examine this
hypothesis, immediately after the last session of cocaine SA we infused the
GluN2A-selective antagonist, TCN-201, or the GluN2B-selective antagonist, Ro25-6981, into the dmPFC before BDNF and then 2hr after intracranial infusions,
12

rats were euthanized for immunoblotting to assess the effect of cocaine SA and
intra-dmPFC BDNF on phosphorylation of ERK, GluN2A (Y1325) and GluN2B
(Y1472).
Specific Aims
Specific Aim 1. Examine whether glutamatergic neuronal activity, more
specifically, GluN2A or GluN2B-containing NMDAR activity underlies intradmPFC BDNF-mediated suppression of cocaine-seeking induced by context-cue
or cocaine-associated cue.
Specific Aim 2. Assess whether GluN2A-containing NMDAR or GluN2Bcontaining NMDAR activity underlies intra-dmPFC BDNF-mediated normalization
of cocaine-induced dephosphorylation in pERK, pGluN2A (Y1325) and pGluN2B
(Y1472) in the dmPFC.
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CHAPTER 2

NMDA RECEPTORS MEDIATE THE SUPPRESSIVE EFFECT OF AN INTRADMPFC BDNF INFUSION ON COCAINE-SEEKING

Introduction
Drug addiction is a chronic, relapsing brain disorder induced by long-lasting
dysregulation of synaptic adaptation (Koob and Volkow, 2010; Weiss et al., 2001;
Kalivas and Volkow, 2005). The glutamatergic projection of the dorsomedial
prefrontal cortex (dmPFC) to the nucleus accumbens core (NAc core) is
associated with reinstatement of cocaine-seeking after extinction by cocaineconditioned context, cue, and cocaine-prime (Fuchs et al., 2005; McLaughlin and
See, 2003; Park et al., 2002; McFarland et al., 2003). Brain-derived neurotrophic
factor (BDNF) is expressed in the cortico-accumbens pathway where, as in other
brain

regions,

it

modulates

synaptic

plasticity

and

glutamatergic

neurotransmission in an activity-dependent manner (McGinty et al., 2010; Korte
et al., 1998; Figurov et al., 1996; Lessmann and Heumann, 1998; Kang and
Schuman, 1995; Bramham and Messaoudi, 2005). BDNF binds to and activates
tropomyosin-receptor kinase B (TrkB), leading to the activation of mitogenactivated extracellular signal-regulated kinase (ERK), phosphoinositol 3-kinase,

14

and phospholipase C gamma1 intracellular signaling (Huang and Reichardt,
2003; Reichardt, 2006). Of these kinase signaling cascades, ERK1/2-MSK2
activation was found to exclusively mediate BDNF’s ability to phosphorylate
CREB in cortical neurons (Simon et al., 2004). We previously showed that
infusion of exogenous BDNF into the dmPFC immediately after the last session
of cocaine SA effectively suppresses cocaine-seeking induced by cocaineconditioned context, cue, or cocaine-prime through Trk receptor-mediated ERK
activation (Berglind et al., 2007; Whitfield et al., 2011) and through normalization
of the cocaine-mediated dysregulation in extracellular glutamate level in NAc
core in rats with a cocaine SA history (Berglind et al., 2009).
Glutamatergic neuronal activity is essential for the maintenance of BDNFmediated ERK activity and for BDNF-induced potentiation of glutamate
transmission in cortical cultures (Matsumoto et al., 2006). Of the receptors which
mediate glutamatergic neuronal activity, NMDARs are known to suppress
cocaine-seeking. NMDAR co-agonist, D-serine, effectively extinguishes cocaineseeking both in cocaine-induced conditioned place preference (CPP) and in a
cocaine SA paradigm (Hammond et al., 2013; Kelamangalath et al., 2009;
Kelamangalath and Wagner, 2010). In contrast, systemic injection of NMDAR
antagonist MK-801 promotes reinstatement of cocaine-seeking (De Vries et al.,
1998). GluN2 (A-D) are modulatory subunits of NMDARs and GluN2A and
GluN2B subunits are highly expressed in the cerebral cortex (Lau and Zukin,
2007; Yashiro and Philpot, 2008). Given that glutamatergic neuronal activity
underlie BDNF-mediated ERK activity and glutamate neurotransmission, both of
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which are the underlying mechanisms of BDNF’s suppressive effect on cocaineseeking, we hypothesized that PFC synaptic activity contributes to BDNFinduced ERK activity in the dmPFC that underlies BDNF’s ability to suppress
cocaine-seeking. The initial study examined whether blocking all dmPFC
synaptic

activity

with

a

mixture

of

AMPAR/NMDAR

antagonists

(CNQX/LY235959) would prevent an intra-dmPFC BDNF infusion immediately
after the end of cocaine SA from suppressing subsequent cocaine-seeking.
Because a previous study from our lab found changes in the phosphorylation of
NMDAR, but not AMPAR, subunits during early withdrawal from short access
cocaine SA (Sun et al., 2013), after assessing the essential role of synaptic
activity on BDNF’s suppressive effects, this study also examined the role of
regulatory GluN2 subunits in BDNF‘s suppressive effect on cocaine-seeking. For
this purpose, rats were infused with a GluN2A-selective antagonist, TCN-201, or
a GluN2B-selective antagonist, Ro-25-6981, into the dmPFC before intra-dmPFC
BDNF.
Materials and Methods
Experimental Design. Figure 2.1 illustrates the design of all experiments in which
rats were trained to self-administer cocaine for 2 hr/day and received intracranial
infusions immediately after the end of cocaine SA. In Experiments 1-3, after
intracranial infusions of glutamate receptor antagonists prior to BDNF or PBS,
rats underwent abstinence, a post-abstinence (PA) test under extinction
conditions, followed by extinction of lever pressing, and a conditioned-cue test as
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described below. A schematic flowchart of each experiment is shown in Figure
2.1.

Figure 2.1. Schematic representation of the experimental designs for
experiments 1-3.

Animals and surgery. Adult male Sprague Dawley rats (Charles River
Laboratories, Raleigh, NC, USA; 275-300g on arrival) were individually placed in
a temperature- and humidity-controlled room on a reversed light/dark cycle (lights
off from 6AM-6PM). Rats were provided standard rodent chow with water
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available ad libitum. All experimental procedures were conducted under the
guidelines and approval of the Institutional Animal Care and Use Committee
(IACUC) of the Medical University of South Carolina and the National Institutes of
Health (NIH) Guide for the Care and Use of Laboratory Animals (NIH publication
no. 80-23, revised 1996). Rats were housed singly in their home cages at least 4
days for acclimation before surgery.
On the day of surgery, rats were anesthetized with a mixture of ketamine
(66 mg/kg, i.p.) and xylazine (1.33 mg/kg,i.p.), and then equithesin (0.5 ml/kg, i.p.)
followed by ketorolac (2.0 mg/kg, i.p.). One end of a catheter was placed into the
right jugular vein and the other end was connected to the back mount cannula
pedestal (Med Associates) for intravenous infusions. After catheterization, 26
gauge bilateral guide cannulae (Plastics One) were placed 1 mm above the
dmPFC target region [anterior-posterior (AP), +3.0; medial-lateral (ML), +/- 0.6;
dorsoventral (DV),-1.6 relative to dural surface] (Paxinos and Watson 2005).
Guide cannulae were affixed to the skull with cranioplastic cement and steel
screws. Stylets the same length as guide cannulae (Plastics One) were inserted
into the guide cannulae to avoid blockage throughout the experiment. Following
surgery, rats were infused intravenously with 0.1 ml of cefazolin (33.3 mg/kg, i.p.)
as well as an anti-microbial lock solution TCS (0.1ml; Norfolk Access
Technologies) twice daily for 5 days.
Cocaine self-administration. After at least 5 days of surgical recovery, rats were
subject to cocaine SA under a FR1 reinforcement schedule for 12-14 days
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(2hr/day). Rats were provided with a moderately restricted amount of food (20g
standard chow/day) starting 1d before SA training to the last day of cocaine SA.
The SA chamber contained a lever on the left (inactive lever) and right (active
lever) side of one wall, and a circular stimulus light above each lever. A cocaine
infusion line was connected to a swivel (Instech Laboratories) that allowed the
rats to freely move in the chamber. Rats pressing the active lever were infused
with cocaine hydrochloride (0.2mg/infusion; National Institute on Drug Abuse,
Research Triangle Park, NC) through a computer-controlled infusion pump
paired with both light and tone cues (a white stimulus light above the active lever;
2 kHz, 15 dB above ambient noise). Following each cocaine infusion, there was a
20s timeout period when pressing on the active lever was counted, but no
infusion of cocaine occurred. Pressing left (inactive) levers also was counted
without any programmed consequences. The criterion for cocaine SA was more
than 10 infusions per day.
Intracranial infusions into the dmPFC. Immediately after the final SA session in
all experiments, a 33 gauge bilateral infusion injector (Plastics One) was inserted
into the guide cannula so that it protruded 1 mm below the tip of the guide
cannula, targeting the anterior cingulate/prelimbic cortex. All intracranial infusions
were conducted using 10 ul Hamilton gas-tight syringes connected to an infusion
pump (Harvard Apparatus) that was programmed to deliver a 0.5 ul volume per
side (0.25 ul/min). Injectors remained in the guide cannula for 1 min before and
after infusions. In Experiment 1, a mixture of the AMPAR antagonist, CNQX (0.1
nmol/0.5 ul/side; Tocris; Pierce et al., 1996) and the NMDAR antagonist,
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LY235959 (10 ng/0.5 ul/side; Tocris; Kenny et al., 2009) or 1% DMSO in PBS,
was infused into the dmPFC 20 min before recombinant human BDNF (0.75
ug/0.5 ul/side; R&D Systems) or PBS. In Experiment 2,, the GluN2A-selective
NMDAR antagonist, TCN-201 (0.1 nmol/0.5 ul/side; Tocris;) or 2% DMSO in PBS,
was infused into the dmPFC. In Experiment 3, the GluN2B-selective NMDAR
antagonist, Ro-25-6981 (2 ug/0.5 ul/side; Tocris;) or PBS, was infused into the
dmPFC.
Post-abstinence relapse test, extinction, and cue-induced reinstatement test.
After dmPFC infusions, rats were placed back into their home cages for 6 days of
abstinence before a 2-hr post-abstinence (PA) relapse test under extinction
conditions. During this test, active (right) and inactive (left) lever presses were
recorded but did not lead to any programmed consequences. Following the PA
test, rats underwent further extinction training until meeting criteria (2hr/day, 6 or
more days and less than 10 active lever presses during the last 2 consecutive
days) before the cue-induced reinstatement test. During extinction training,
responses on both active and inactive levers were recorded, but resulted in no
programmed consequences.

During the 2-hr cue-induced reinstatement test,

both active and inactive lever presses were recorded but whereas pressing the
active lever resulted in presentation of cocaine-paired cues (light plus tone),
inactive lever pressing had no programmed consequences.
Verification of cannula placements. Cannula placements are shown in Figure 2.2.
The rats were decapitated without anesthesia; their brains were immediately
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frozen in isopentane (-20°C for 30 sec) and kept at -80°C before 40 µm sections
were cut in a cryostat, and cannula placements within the dmPFC were
confirmed by Nissl-staining. Only cannulae located within the target region of
dmPFC, including the prelimbic or anterior cingulate cortex, were mapped and
included in the data set for statistical analysis.

Figure 2.2. Cannula placements from Experiments 1-3. Graphical
representation of the tip of the intracranial infusion cannula within the target area
of the dmPFC (anterior cingulate and prelimbic cortex) (shown as small filled
dots).

Statistical analysis. For the analysis of behavioral data one-way ANOVA followed
by Student–Newman–Keuls (SNK) multiple-comparison tests were performed to
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compare active lever presses of all four experimental groups during either last 3d
of cocaine SA, PA relapse test, last 2d of extinction or cue-induced reinstatement
test. To compare active lever presses of the same experimental group between
two different time points (last 3d of cocaine SA vs PA relapse test, or last 2d of
extinction vs cue-induced reinstatement test), within-sample paired t-tests were
used for the analysis. When the p-value was <0.05, results were considered
statistically significant.
Results
Histology
Cannula placements for rats in Experiments 1- 3 are shown in Figure 2.2.
Cannula placements extended from AP 3.0-4.7 and punches extended from
2.76-4.7. Cannula placements that were located outside the dmPFC (n=2) were
excluded from the schematic mapping and the data set for statistical analysis.
Experiment 1: The ability of BDNF to suppress cocaine-seeking requires
ionotropic glutamate receptor-mediated neuronal activity in the dmPFC
To examine whether glutamate-mediated neuronal activity was required for the
suppressive effect of intra-dmPFC BDNF on cocaine-seeking, rats were divided
into four experimental groups that were subject to an intra-dmPFC infusion of a
mixture of AMPAR/NMDAR antagonists (CNQX/LY235959) or 1% DMSO in PBS
20 min before BDNF or PBS infusion immediately after the final session of
cocaine SA (see Fig. 2.1A). One-way ANOVA showed that during the last 3 days
of cocaine SA before intracranial infusions, active (right) lever presses were not
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significantly different among the four groups (F(3,16)=0.27, p=0.85; Fig. 2.3A).
Paired t-tests showed that during the PA relapse test, DMSO/PBS (t4=5.96,
p<0.01), CNQX/LY235959-PBS (t4=2.78, p<0.05) and CNQX/LY235959-BDNFinfused rats (t4=4.74, p<0.01) but not DMSO/BDNF-infused rats (t4=2.10, p=0.10)
showed significantly more active lever presses than during the last 3 days of
cocaine SA.
A one-way ANOVA revealed that during the PA relapse test after
intracranial infusions, active (right) lever presses were significantly different
among the four groups (F(3,16)= 4.71, p=0.02 ; Fig. 2.3A). SNK multiple
comparison tests revealed that rats infused with DMSO/BDNF exhibited
significantly less active lever pressing than DMSO/PBS-infused rats (p<0.05) and
CNQX/LY235959/BDNF-infused rats pressed the previously active levers more
than DMSO/BDNF-infused rats (p<0.01), indicating that CNQX/LY235959
blocked the suppressive effect of BDNF on cocaine-seeking during the PA
relapse test. SNK multiple comparison tests also showed that during the PA
relapse test, there was no significant difference in active lever pressing between
DMSO/PBS and CNQX/LY235959/PBS-infused rats (p>0.05), confirming that the
dose of CNQX/LY235959 chosen for the study effectively blocked BDNFmediated behavior changes only, leaving cocaine-induced behaviors unaffected.
After the PA relapse test, rats were subjected to extinction training. A oneway ANOVA showed that during the last two consecutive days of extinction (Fig.
2.3B), the average number of active (right) lever presses was not significantly
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different among the four groups (F(3,16)=0.03, p=0.99). Paired t-tests indicated
that during the cue-induced reinstatement test, DMSO/PBS (t4=10.65, p<0.001),
DMOS/BDNF (t4=4.14, p<0.05), CNQX/LY235959/PBS (t4=4.29, p<0.05), and
CNQX/LY235959/BDNF-treated rats (t4=4.81, p<0.01) showed significantly
greater active lever responses than during the last 2 days of extinction training.
A one-way ANOVA revealed that during the cue-induced reinstatement
test after intracranial infusions, active (right) lever presses were significantly
different among the four groups (F(3,16)=4.58, p=0.02; Fig. 2.3B). SNK tests
revealed that DMSO/BDNF-infused rats pressed the formerly active lever
significantly

less

than

DMSO/PBS-infused

rats

(p<0.001)

and

CNQX/LY235959/BDNF-infused rats responded significantly more on the active
levers than DMSO/BDNF-infused rats (p < 0.001), indicating CNQX/LY235959
blocked the suppressive effect of BDNF on cue-induced reinstatement of
cocaine-seeking. In addition, SNK multiple comparison tests showed that during
the cue-induced reinstatement test, there was no significant difference in active
lever pressing between DMSO/PBS and CNQX/LY235959/PBS-infused rats
(p>0.05), indicating that the dose of CNQX/LY235959 chosen for the study
effectively blocked BDNF-mediated behavior changes only, leaving cocaineinduced behaviors unaffected.
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Figure 2.3. Infusion of
CNQX/LY235959 into the
dmPFC blocked BDNF’s
suppressive effect on
cocaine-seeking
during
the post-abstinence (PA)
relapse test and cueinduced
reinstatement
test. (A) C/L effects on PA
test responding after one
week of abstinence. Left:
During the last 3d of
cocaine SA, the average
number of active lever
presses was similar among
groups
(n=
5/group).
Immediately after the last
cocaine SA session, the rats
were given intra-dmPFC
infusions of C/L, and after
one week of home cage
abstinence,
they
were
subjected to the PA test.
Right: During the PA test, all
other infusion groups except
the D-B group showed
significantly greater active
lever pressing compared
with responses during the
last 3d of cocaine SA (@p <
0.05, @@p < 0.01). DMSO
(D)-B
rats
showed
significantly less active lever pressing than D-PBS (P) controls (*p < 0.05), but
C/L infusion before BDNF (C/L-B) significantly inhibited the suppressive effect of
BDNF on active lever pressing compared to the D-B group (##p < 0.01). (B) C/L
effects on cue-induced reinstatement after extinction training (n=5/group). Left:
Rats were subject to extinction of active lever pressing until reaching a common
response criterion. The average number of active lever presses during the last 2d
of extinction training was not significantly different among groups. Right: During
the cue-induced reinstatement test, each experimental group exhibited
significantly greater active lever pressing compared with responses during the
last 2d of extinction training (@p < 0.05, @@p < 0.01, @@@p < 0.001). D-B rats
pressed the formerly active lever significantly less than D-P controls (***p <
0.001). A C/L infusion before BDNF treatment significantly decreased the
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inhibitory effect of BDNF on cocaine-seeking compared with the D-B group (###p
< 0.001). D-B=DMSO vehicle before BDNF, C/L-P=CNQX/LY235959 before PBS,
C/L-B= CNQX/LY235959 before BDNF.

Experiment 2: Activity of GluN2A-containing NMDA receptors in the dmPFC
is necessary for the suppressive effect of intra-dmPFC BDNF on cocaineseeking
Once Experiment 1 established that synaptic activity was necessary for the
suppressive effect of intra-dmPFC BDNF on cocaine-seeking, we reasoned that
NMDA receptors were the likely drivers because our previous studies
demonstrated that NMDA, but not AMPA, receptor functionality was altered by
short access cocaine SA (Sun et al., 2013). To examine the role of the GluN2A
subunit-containing NMDARs in the suppressive effect of BDNF on cocaineseeking, rats were divided into four experimental groups that were subjected to
intracranial infusion of the GluN2A-selective antagonist, TCN-201, or 2% DMSO
in PBS 20 min before BDNF or PBS infusion immediately after the last session of
cocaine SA (see Fig. 2.1B). A One-way ANOVA showed that during the last 3
days of cocaine SA before intracranial infusions, active (right) lever pressing was
not significantly different among the four groups (F(3,27)=0.34, p=0.80; Fig. 2.4A).
Paired t-tests showed that during the PA relapse test, DMSO/PBS (t6=7.46,
p<0.001), TCN-201/PBS (t9=2.90, p<0.05) and TCN-201/BDNF-infused rats
(t6=3.97, p<0.01) but not DMSO/BDNF-infused rats (t6=1.63, p=0.15) showed
significantly more active lever presses than during the last 3 days of cocaine SA.
A one-way ANOVA revealed that during the PA relapse test after
intracranial infusions, active (right) lever presses were significantly different
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among the four groups (F(3,27)= 4.07, p=0.02 ; Fig. 2.4A). SNK multiple
comparison tests revealed that rats infused with DMSO/BDNF pressed the active
lever significantly less than DMSO/PBS-infused rats (p<0.01). TCN-201/BDNFinfused rats pressed the previously active levers significantly more than
DMSO/BDNF-infused rats (p<0.01), indicating that TCN-201 blocked the
suppressive effect of BDNF on cocaine-seeking during the PA test. SNK multiple
comparison tests also showed that during the PA test, there was no significant
difference in active lever pressing between DMSO/PBS and TCN-201/PBSinfused rats (p>0.05), confirming that the doses of TCN-201 chosen for the study
effectively blocked BDNF-mediated behavior changes only, leaving cocaineinduced behaviors unaffected.
After the PA test, rats were subjected to extinction training. A one-way
ANOVA showed that during the last two consecutive days of extinction (Fig.
2.4B), active (right) lever responses were not significantly different among the
four groups (F(3,25)=0.35, p=0.79). Paired t-tests indicated that during the cueinduced reinstatement test, DMSO/PBS (t6=7.52, p<0.001), DMOS/BDNF
(t6=4.30, p<0.01), TCN-201/PBS (t8=5.81, p<0.001), and TCN-201/BDNF-treated
rats (t5=10.25, p<0.001) showed significantly greater active lever responses than
during the last 2 days of extinction training.
A one way ANOVA found that during the cue-induced reinstatement test
after intracranial infusions, active (right) lever presses were significantly different
among the four groups (F(3,25)= 4.79, p=0.01; Fig. 2.4B). SNK tests revealed that
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DMSO/BDNF-infused rats pressed the active lever less than DMSO/PBS-infused
rats (p<0.01). TCN-201/BDNF-infused rats responded significantly more on the
active levers than DMSO/BDNF-infused rats (p < 0.05), indicating TCN-201
blocked the suppressive effect of BDNF on cue-induced reinstatement of
cocaine-seeking. In addition, SNK multiple comparison test showed that during
the cue-induced reinstatement test, there was no significant difference in active
lever pressing between DMSO/PBS and TCN-201/PBS-infused rats (p>0.05),
indicating that the dose of TCN-201 chosen for the study effectively blocked
BDNF-mediated behavior changes only, leaving cocaine-induced behaviors
unaffected.

Figure 2.4. Infusion of TCN-201 (T) into the
dmPFC blocked BDNF’s (B) suppressive
effect on cocaine-seeking during the postabstinence (PA) relapse test and cueinduced reinstatement test. (A) TCN-201
effects on PA test responding after one week
of abstinence. Left: During the last 3d of cocSA, the average number of active lever
presses was similar among groups (n=10 in TP group; n=7 in other groups). Immediately
after the last cocaine SA session, the rats were
given intra-dmPFC infusions of TCN-201, and
after one week of home cage abstinence, they
were subjected to the PA test. Right: During
the PA test, all groups except the D-B group
pressed the formerly active lever significantly
less than during the last 3d of cocaine SA (@p
< 0.05, @@p < 0.01, @@@p < 0.001). The D-B
group showed significantly less active lever
pressing compared with D-P controls (**p <
0.01). However, TCN-201 pretreatment before
BDNF (T-B) significantly decreased the
suppressive effect of BDNF on active lever
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pressing compared with the D-B group (##p < 0.01). (B) TCN-201 effects on cueinduced reinstatement after extinction training (n=9 in T-P group; n=6 in T-B
group; n=7 in other groups). Left: All rats were given extinction training until
reaching a common response criterion. The average number of active lever
presses during the last 2 d of extinction training was not significantly different
among groups. Right: During the cue-induced reinstatement test, all four
experimental groups showed significantly greater active lever pressing test than
the responses during the last 2d of extinction training (@@p < 0.01, @@@p <
0.001). D-B treated rats exhibited significantly less active lever pressing than D-P
controls (**p < 0.01). Infusion of TCN-201 before BDNF significantly inhibited the
ability of BDNF to suppress cocaine-seeking compared to the D-B group (#p <
0.05). D-P=DMSO vehicle before PBS, T-P=TCN-201 before PBS, T-B=TCN-201
before BDNF.

Experiment 3: Activity of GluN2B-containing NMDA receptors in the dmPFC
is essential for the inhibitory effect of intra-dmPFC BDNF on cocaineseeking
To examine the role of the GluN2B subunit-containing NMDARs in the
suppressive effect of BDNF on cocaine-seeking behavior, rats were divided into
four experimental groups that were subject to intracranial infusion of the GluN2Bselective antagonist, Ro-25-6981, or PBS 20 min before BDNF or PBS infusion
immediately after the last session of cocaine SA (see Fig. 2.1C). One-way
ANOVA showed that during the last 3 days of cocaine SA before intracranial
infusions, active (right) lever pressing was not significantly different among the
four groups (F(3,21)=0.53, p=0.67; Fig. 2.5A). Paired t-tests showed that during the
PA relapse test, PBS/PBS (t4=3.87, p<0.05), PBS/BDNF (t6=2.45, p<0.05), Ro25-6981/PBS (t5=10.46, p<0.001), and Ro-25-6981/BDNF-infused rats (t6=5.52,
p<0.01) showed significantly more active lever presses than during the last 3
days of cocaine SA.
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A one way ANOVA revealed that during the PA relapse test after
intracranial infusions, active (right) lever presses were significantly different
among the four groups (F(3,21)= 4.88, p=0.01; Fig. 2.5A). SNK tests revealed that
during the PA relapse test, rats infused with PBS/BDNF exhibited significantly
less active lever pressing than PBS/PBS-infused rats (p<0.001) and Ro-256981/BDNF-infused rats pressed the previously active levers more than
PBS/BDNF-infused rats (p<0.001), indicating that Ro-25-6981 blocks the
suppressive effect of BDNF on cocaine-seeking during the PA relapse test. SNK
multiple comparison test followed by one way ANOVA also showed that during
the PA relapse test, there was no significant difference in active laver pressing
between PBS/PBS Ro-25-6981/PBS-infused rats (p>0.05), confirming that the
doses of Ro-25-6981 chosen for the study effectively blocked BDNF-mediated
behavior changes only, leaving cocaine-induced behaviors unaffected.
After the PA relapse test, rats were subject to extinction training. One-way
ANOVA showed that during the last two consecutive days of extinction (Fig. 2.5B)
active (right) lever presses were not significantly different among the four groups
(F(3,19)=0.58, p=0.64). Paired t-tests indicated that during the cue-induced
reinstatement test, PBS/PBS (t4=6.21, p<0.01), PBS/BDNF (t5=8.96, p<0.001),
Ro-25-6981/PBS (t5=8.15, p<0.001), and Ro-25-6981/BDNF-treated rats (t5=4.94,
p<0.01) showed significantly greater active lever responses than during the last 2
days of extinction training.
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A one way ANOVA revealed that during the cue-induced reinstatement
test after intracranial infusions, active (right) lever presses were significantly
different among the four groups (F(3,19)= 4.92 , p=0.01; Fig. 2.5B). SNK tests
revealed that during the cue-induced reinstatement test PBS/BDNF-infused rats
showed significantly less active lever presses than PBS/PBS-infused rats
(p<0.01)

and

Ro-25-6981/BDNF-infused

rats

showed

significantly

more

responses on the active levers than PBS/BDNF-infused rats (p < 0.001),
indicating Ro-25-6981 blocked the suppressive effect of BDNF on cue-induced
reinstatement of cocaine-seeking. In addition, SNK multiple comparison test
followed by one way ANOVA also showed that during the cue-induced
reinstatement test, there was no significant difference in active laver presses
between PBS/PBS and Ro-25-6981/PBS-infused rats (p>0.05), indicating that
the dose of Ro-25-6981 chosen for the study effectively blocked BDNF-mediated
behavior changes only, leaving cocaine-induced behaviors unaffected.
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Figure 2.5. Infusion of Ro-25-6981 (Ro)
into the dmPFC blocked BDNF’s (B)
suppressive effect on cocaineseeking during the post-abstinence
(PA) relapse test and cue-induced
reinstatement test. (A) Ro effects on
PA test responding. Left: During the last
3d of cocaine SA, the average number
of active lever presses was similar
among groups (n=5 in P-P; n=6 in Ro-P;
n=7 in other groups). Immediately after
the last cocaine SA session, the rats
were given intra-dmPFC infusions of Ro,
and after one week of home cage
abstinence, they were subjected to the
PA relapse test. Right: During the PA
test, all four groups pressed the formerly
active lever significantly more than
during last 3d of cocaine SA (@p < 0.05,
@@
p < 0.01,@@@p < 0.001). The P-B
group showed significantly less active
lever pressing compared with P-P
controls (***p< 0.001). However, Ro
pretreatment before BDNF (R-B)
significantly blocked the suppressive
effect of BDNF on active lever pressing
compared with the P-B group (###p <
0.001). (B) Ro effects on cue-induced
reinstatement after extinction training
(n=5 in P-P; n=6 in other groups). Left:
All rats were given extinction training
until reaching a common response criterion. The average number of active lever
presses during the last 2 d of extinction training was not significantly different
among groups. Right: During the cue-induced reinstatement test, all four
experimental groups pressed the active lever significantly more than during the
last 2d of extinction training (@@p<0.01, @@@p < 0.001). P-B treated rats
exhibited significantly less active lever pressing than P-P controls (**p < 0.01).
Infusion of Ro before BDNF significantly inhibited the ability of BDNF to suppress
cocaine-seeking compared to the P-B group (###p < 0.001). The bar graphs
indicate the mean ± SEM. P-P=PBS before PBS, P-B=PBS before BDNF, Ro-P=
Ro-25-6981 before PBS, Ro-B= Ro-25-6981 before BDNF.
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Discussion
CNQX/LY235959, TCN-201, or
suppression of cocaine-seeking.

Ro-25-6981

inhibited

BDNF-mediated

Infusion of TCN-201, or Ro-25-6981 into the dmPFC blocked the suppressive
effect of BDNF on cocaine-seeking during a post-abstinence relapse test and a
cocaine-conditioned cue-induced reinstatement test after extinction without
affecting cocaine-seeking in PBS-infused rats. These findings indicate that the
activity of ionotropic glutamate receptors, specifically GluN2A- or GluN2Bcontaining NMDARs, in the dmPFC is required for BDNF to suppress cocaineseeking. A previous study supports the functional role of NMDARs in the
suppressive effect of BDNF on cocaine-seeking. In the infralimbic cortex, TrkB
activation promotes extinction learning of a cocaine-induced conditioned place
preference (CPP) via GluN2B-containing NMDARs (Otis et al., 2014).
Intra-dmPFC BDNF infusion attenuates cocaine-seeking induced by
cocaine-conditioned context, cue, or cocaine-prime via Trk receptor-mediated
ERK activation in the dmPFC (Whitfield et al., 2011). BDNF upregulates the open
probability of NMDAR through TrkB in vitro (Levine et al., 1998). In hippocampal
cultures, BDNF increases NMDAR activity (Crozier et al., 2008). TrkB induces
tyrosine phosphorylation of GluN2B-contatining NMDA receptors via Fyn in the
hippocampus (Mizuno et al., 2003). Fyn-mediated phosphorylations of tyrosines
in the C-terminal domain of GluN2A upregulate the amplitude of glutamateactivated

whole-cell

currents

(Kohr

and

Seeburg,

1996).

Fyn-induced

phsophorylation of GluN2B (Y1472) enhances GluN2B synaptic (Nakazawa et al.,
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2001; Cheung and Gurd, 2001; Goebel-Goody et al., 2009) and surface
expression (Gao and Wolf, 2008). NMDAR activity contributes to ERK activation
in rat anterior cingulate cortex (Cao et al., 2009) and CaMKIIα underlies synaptic
GluN2B-mediated ERK activity in mouse cultured cortical neurons (El Gaamouch
et al., 2012). Therefore, BDNF may activate NMDAR via TrkB-SFK signaling, and
this BDNF-mediated NMDAR activity may contribute to ERK activation, which
supports the role of NMDARs in the suppressive effect of BDNF on cocaineseeking.
Intra-dmPFC infusion of BDNF normalizes a cocaine SA-mediated
decrease in the basal level of extracelluar glutamate and a cocaine-prime
induced increase in extracelluar glutamate level in NAc core of rats, which is
associated with suppression of cocaine-seeking (Berglind et al., 2009). In cortical
neurons, NMDAR activity is required for BDNF-potentiated glutamate release
(Matsumoto et al., 2006). Together, this indicates that NMDAR activity may
underlie BDNF-mediated suppression of cocaine-seeking through its potentiation
of BDNF-mediated glutamatergic neurotransmission.
Infusion of CNQX/LY235959, TCN-201 or Ro-25-6981 in the absence of
BDNF did not alter cocaine-seeking compared to vehicle-infused rats (D-P vs
C/L-P; D-P vs T-P; P-P vs Ro-P), indicating that CNQX/LY235959, TCN-201 or
Ro-25-6981 treatment itself has no effect on cocaine-seeking. As cocaine SA is
known to reduce basal activity of the dmPFC (Sun and Rebec, 2006), NMDA
receptor activity in the dmPFC may be highly suppressed after cocaine SA
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because of voltage-sensitive magnesium ion blockade of NMDARs (MacDonald
and Nowak, 1990). Therefore, due to the suppressed NMDAR activity in the
dmPFC after cocaine SA, either CNQX/LY235959, TCN-201 or Ro-25-6981
infusion itself may not be effective to further reduce AMPAR/NMDAR, GluN2A- or
GluN2B-containing NMDAR activity in the dmPFC, exerting no significant effect
on cocaine-seeking compared to its vehicle. This idea is supported by our
findings of the cocaine SA-mediated decrease in phosphorylation of GluN2A
(Y1325) or GluN2B (Y1472) which will be described in the next chapter. Because
SFK-induced phosphorylation of GluN2A (Y1325) or GluN2B (Y1472) is known to
upregulate NMDAR functions (Gao and Wolf, 2008; Taniguchi et al., 2009;
Nakazawa et al., 2001; Cheung and Gurd, 2001; Goebel-Goody et al., 2009),
cocaine SA-mediated reduction in phosphorylation of GluN2A (Y1325) and
GluN2B (Y1472) in the dmPFC during early withdrawal is an indirect indicator of
NMDAR hypofuntion, leading to subsequent cocaine-seeking.
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CHAPTER 3

ACTIVITY OF BOTH GLUN2A SUBUNIT-CONTAINING NMDA RECEPTORS
AND GLUN2B SUBUNIT-CONTAINING NMDA RECEPTORS IS ESSENTIAL
FOR BDNF’S EFFECT ON ERK, GLUN2A AND GLUN2B
PHOSPHORYLATION

Introduction
In the cortico-accumbens pathway BDNF and its receptor TrkB are highly
expressed and regulate neural plasticity and glutamatergic neurotransmission in
an activity-dependent manner (McGinty et al., 2010; Korte et al., 1998; Figurov et
al., 1996; Lessmann and Heumann, 1998; Kang and Schuman, 1995; Bramham
and Messaoudi, 2005). The previous studies from our lab found that intra-dmPFC
BDNF-mediated ERK activity and normalization of cocaine-induced dysregulation
of glutamatergic neurotransmission in the NAc core underlie the suppressive
effect of BDNF on cocaine seeking induced by context cue, cocaine-conditioned
cue or cocaine-prime (Berglind et al., 2007; Whitfield et al., 2011). Glutamatergic
synaptic activity is essential for the maintenance of BDNF-induced ERK activity
and for BDNF-potentiated glutamate transmission in cortical cultures (Matsumoto
et al., 2006). Further, co-activation of D1 and NMDA receptors synergistically
activates ERK1/2 in PFC (Sarantis et al., 2009).
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BDNF upregulates the open probability of NMDARs in a TrkB-dependent
way, increasing glutamate-induced synaptic transmission in vitro (Levine et al.,
1998). Brief stimulation of synaptic NMDARs mediates ERK activation whereas
sustained stimulation of extrasynaptic NMDARs underlies ERK inactivation
(Ivanov et al., 2006) and BDNF reverses this effect (Mulholland et al., 2008).
Regulation of ERK activity is mediated by GluN2A- and GluN2B-containing
NMDARs that are both located in synaptic and extrasynaptic membranes
(Thomas et al., 2006) and are more highly expressed in the cerebral cortex than
other NMDAR regulatory subunits (Yashiro and Philpot, 2008).
BDNF activation of TrkB promotes the association of TrkB with Src family
kinases (SFK), leading to SFK activation and tyrosine phosphorylation of GluN2A
and GluN2B (Goebel-Goody et al., 2009; Huang and McNamara, 2010; Iwasaki
et al., 1998; Narisawa-Saito et al., 1999). SFK-mediated phosphorylation of
GluN2 subunits increases the expression of both subunits in postsynaptic
density-enriched fractions (Nakazawa et al., 2001; Cheung and Gurd, 2001;
Goebel-Goody et al., 2009). Moreover, SFK-mediated phosphorylation of
GluN2A (Y1325) leads to the potentiation of NMDA-stimulated whole cell
currents (Taniguchi et al., 2009) whereas SFK-mediated phosphorylation of
GluN2B (Y1472) enhances GluN2B surface expression (Gao and Wolf, 2008)
and synaptic expression (Nakazawa et al., 2001; Cheung and Gurd, 2001;
Goebel-Goody et al., 2009). Synaptic GluN2B-containing NMDARs mediate ERK
activation via CaMKIIα in mouse cultured cortical neurons (El Gaamouch et al.,
2012).
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Therefore, we hypothesized that BDNF/TrkB/SKF-mediated stimulation of
synaptic GluN2A-containing NMDARs or GluN2B-contatining NMDARs underlies
the BDNF-induced phosphorylation and activation of ERK in the dmPFC via
CaMKIIα. In this experiment, the effect of BDNF on the phosphorylation of
GluN2A (Y1325) or GluN2B (Y1472) in the dmPFC was examined 2 hr after the
end of cocaine SA sessions. Further, the effect of a GluN2A-selective antagonist,
TCN-201, or a GluN2B-selective antagonist, Ro-25-6981 on BDNF’s effects was
investigated. The reason for choosing the 2 hr timepoint is that previous study
from our lab found that cocaine SA decreases pERK 2 h after the final session of
cocaine SA and intra-dmPFC BDNF increases pERK level in the dmPFC of
cocaine-naive rat at 0.5 h and 2 h, but not 6 h postinfusion and intra-dmPFC
BDNF infused immediately after the last session of cocaine SA prevents the
cocaine SA-mediated reduction in pERK.
Materials and Methods
Experimental Design. Figure 3.1 illustrates the design of all experiments in which
rats were trained to self-administer cocaine for 2 hr/day and received intracranial
infusions immediately after the end of cocaine SA. In Experiment 4, BDNF or
PBS was infused without antagonists into cocaine SA or yoked-saline rats that
were decapitated 2 hr later to investigate the effect of cocaine on GluN2A (Y1325)
and GluN2B (Y1472) and whether BDNF would prevent such effects while
confirming BDNF’s ability to prevent cocaine SA-induced ERK dephosphorylation.
In Experiments 5-6, rats were euthanized 2 hr after intra-PFC infusions of
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glutamate receptor antagonists prior to BDNF or PBS in cocaine SA or yokedsaline rats to investigate whether GluN2A and/or GluN2B antagonists would
block BDNF’s ability to prevent cocaine SA-induced protein dephosphorylation,
leading to cocaine-seeking.

Figure 3.1. Schematic representation of the experimental designs for
experiments 4-6.

Animals and surgery. Adult male Sprague Dawley rats (Charles River
Laboratories, Raleigh, NC, USA; 275-300g on arrival) were individually placed in
a temperature- and humidity-controlled room on a reversed light/dark cycle (lights
off from 6AM-6PM). Rats were provided standard rodent chow with water
available ad libitum. All experimental procedures were conducted under the
guidelines and approval of the Institutional Animal Care and Use Committee
(IACUC) of the Medical University of South Carolina and National Institutes of
Health (NIH) Guide for the Care and Use of Laboratory Animals (NIH publication
no. 80-23, revised 1996). Rats were housed singly in their home cages at least 4
days for acclimation before surgery.
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On the day of surgery, rats were anesthetized with a mixture of ketamine
(66 mg/kg, i.p.) and xylazine (1.33 mg/kg,i.p.), and then equithesin (0.5 ml/kg, i.p.)
followed by ketorolac (2.0 mg/kg, i.p.). One end of a catheter was placed into the
right jugular vein and the other end was connected to the back mount cannula
pedestal (Med Associates) for intravenous infusions. After catheterization, 26
gauge bilateral guide cannulae (Plastics One) were placed 1 mm above the
dmPFC target region [anterior-posterior (AP), +3.0; medial-lateral (ML), +/- 0.6;
dorsoventral (DV),-1.6 relative to dural surface] (Paxinos and Watson 2005).
Guide cannulae were affixed to the skull with cranioplastic cement and steel
screws. Stylets the same length as guide cannulae (Plastics One) were inserted
into the guide cannulae to avoid blockage throughout the experiment. Following
surgery, rats were infused intravenously with 0.1 ml of cefazolin (33.3 mg/kg, i.p.)
as well as an anti-microbial lock solution TCS (0.1ml; Norfolk Access
Technologies) twice daily for 5 days.
Cocaine self-administration. After at least 5 days of surgical recovery, rats were
subject to cocaine SA under a FR1 reinforcement schedule for 12-14 days
(2hr/day). Rats were provided with a moderately restricted amount of food (20g
standard chow/day) starting 1d before SA training to the last day of cocaine SA.
The SA chamber contained a lever on the left (inactive lever) and right (active
lever) side of one wall, and a circular stimulus light above each lever. A cocaine
infusion line was connected to a swivel (Instech Laboratories) that allowed the
rats to freely move in the chamber. Rats pressing the active lever were infused
with cocaine hydrochloride (0.2mg/infusion; National Institute on Drug Abuse,
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Research Triangle Park, NC) through a computer-controlled infusion pump
paired with both light and tone cues (a white stimulus light above the active lever;
2 kHz, 15 dB above ambient noise). Following each cocaine infusion, there was a
20s timeout period when pressing on the active lever was counted, but no
infusion of cocaine occurred. Pressing left (inactive) levers also was counted
without any programmed consequences. The criterion for cocaine SA was more
than 10 infusions per day. In Experiments 4-6, each rat in the yoked-saline group
was matched to a rat in the cocaine SA group and was infused with 0.9% saline
instead of cocaine when its paired rat received a cocaine infusion.
Intracranial infusions into the dmPFC. Immediately after the final SA session in
all experiments, a 33 gauge bilateral infusion injector (Plastics One) was inserted
into the guide cannula so that it protruded 1 mm below the tip of the guide
cannula, targeting the anterior cingulate/prelimbic cortex. All intracranial infusions
were conducted using 10 ul Hamilton gas-tight syringes connected to an infusion
pump (Harvard Apparatus) that was programmed to deliver a 0.5 ul volume per
side (0.25 ul/min). Injectors remained in the guide cannula for 1 min before and
after infusions. In Experiment 5, the GluN2A-selective NMDAR antagonist, TCN201 (0.1 nmol/0.5 ul/side; Tocris;) or 2% DMSO in PBS, was infused into the
dmPFC. In Experiment 6, the GluN2B-selective NMDAR antagonist, Ro-25-6981
(2 ug/0.5 ul/side; Tocris;) or PBS, was infused into the dmPFC.
Verification of cannula placements and dmPFC punches. At the 2 hr time point
after intracranial infusion in Experiments 4-6, rats were decapitated without

41

anesthesia, their brains were rapidly removed and frozen in isopentane (-20°C
for 30 sec), and stored at -80°C. Brains were blocked in a cryostat, and 2 mm
punches were taken in the dmPFC at the level of AP= 2.8-4.7. Cannula
placements from rats in Experiments 4-6 are shown in Figure 3.2. Cannula
placements were verified to determine that the dmPFC was punched and the AP
extent of the punch was noted, but the precise placements were not mapped.

Figure 3.2. Areas punched from Experiments 4-6. Cannula placements within
the dmPFC were verified by inspection during brain punching. Punch target was
the anterior cingulate-prelimbic cortical areas (shown as large, unfilled circles).
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Immunoblotting. For cell lysis and protein extraction, punched dmPFC tissue was
sonicated in RIPA buffer and then centrifuged for 20 min at 10,000 g at 4°C.The
resulting supernatant was collected and protein concentrations were measured
using the BCA protein assay kit (Thermo Scientific). The same volume of protein
sample was mixed with Laemmli buffer and heated for 5 minutes at 95°C and
then loaded onto a 7.5% polyacrylamide gel (Bio-Rad). After separation of
proteins using SDS-PAGE, gels were transferred onto polyvinylidene difluoride
(PVDF) membranes (Life Technologies). After 1 hr blocking in 5% non-fat milk in
Tris-buffered saline containing 0.1% Tween-20 (TBST) at room temperature,
membranes were incubated overnight at 4°C with primary antibodies against
pERK (1:4000, Cell Signaling Technology), pGluN2A (Y1325) (1:500, Abcam),
and pGluN2B (Y1472) (1:500, Sigma-Aldrich) in 5% non-fat milk in TBST (pERK,
pGluN2B) or in 5% bovine serum albumin (BSA) in TBST (pGluN2A). After three
washes with 5% non-fat milk in TBST for 10 min each, membranes were
incubated with goat anti-rabbit horseradish peroxidase (HRP)-conjugated
secondary antibody (1:2000 for pERK, 1:3000 for pGluN2A, 1:1000 for pGluN2B;
Millipore) for 1 hr at room temperature. After washing in TBST three times for 10
min, membranes were immersed in ECL Plus (Pierce) for 3-5 min followed by
exposure to Hyperfilm (GE Healthcare Life Sciences) and then developed. After
10-15 min of stripping with ReBlot Plus Mild Antibody Stripping Solution
(Millipore), membranes were re-probed for total proteins with primary antisera
against total ERK (1:6000, Cell Signaling Technology), GluN2A (1:2000,
Millipore), and GluN2B (1:500, BD Biosciences). The integrated density for each
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protein was measured using Image J software (National Institutes of Health). To
confirm whether equal amounts of protein were loaded in each lane, the samples
were incubated with anti-calnexin antibody (1:6000, Enzo Life Sciences), and the
ratio of total protein/calnexin (CNX) in each group was calculated and compared
among groups. As there was no difference in total protein/CNX among groups,
the ratio of each phosphoprotein/total protein was used for statistical analysis.
Statistical analysis. Two-way or one-way ANOVAs followed by Student–
Newman–Keuls (SNK) multiple-comparison tests, or unpaired t-tests were used
for the analysis of immunoblotting data. When the p-value was <0.05, results
were considered statistically significant.
Results
Histology
The AP extent of the 2 mm punches in Experiments 4-6 are shown in Figure 3.2.
Cannula placements extended from AP 3.0-4.7 and punches extended from 2.84.7. All cannula placements were located within the dmPFC and included in the
schematic mapping and the data set for statistical analysis.
Experiment 4: intra-PFC BDNF prevented cocaine SA-induced reduction of
pERK, pGluN2A and pGluN2B levels in the dmPFC during early withdrawal
To detect the effect of BDNF on phosphoproteins including pERK, pGluN2A
(Y1325) and pGluN2B (Y1472) in the dmPFC, the levels of protein expression
were measured at the 2hr time point after infusion of BDNF or PBS into the
dmPFC in rats with a cocaine SA or yoked-saline history (see Fig.3.1A). Two44

way ANOVA found that the drug (cocaine vs saline; F(1,25)=4.61, p<0.05) and
the intracranial infusion (BDNF vs PBS; F(1,25) =14.61, p<0.001) had a significant
main effect on pERK (Fig. 3.3A), but there was no interaction between drug and
infusion (F(1,25)=1.01, p=0.32). SNK multiple comparison tests revealed that, as
previously reported (Whitfield et al., 2011), cocaine SA caused a profound
reduction in pERK expression in the dmPFC of PBS-infused rats compared to
yoked-saline treated rats infused with PBS (S-P vs C-P, p<0.05) and BDNF
infusion not only prevented this decrease in cocaine SA rats (C-P vs C-B, p<0.01)
but augmented the level of pERK in yoked-saline-treated rats (S-P vs S-B,
p<0.05).
Two-way ANOVA found that the drug (cocaine vs saline; F(1,26) = 4.73, p <
0.05) and intracranial infusion (BDNF vs PBS; F(1,26) = 20.33, p < 0.001) had a
significant main effect on pGluN2A (Y1325), (Fig. 3.3B), but there was no
interaction between drug and infusion (F(1,26)=0.12, p=0.74). SNK multiple
comparison tests revealed that cocaine SA caused a profound reduction in
pGluN2A (Y1325) expression in the dmPFC of PBS-infused rats compared to
yoked-saline treated rats infused with PBS (S-P vs C-P; p<0.05) and BDNF
infusion not only prevented this decrease in cocaine SA rats (C-P vs C-B, p<0.05)
but augmented the level of pGluN2A (Y1325) in yoked-saline-treated rats (S-P vs
S-B, p<0.01).
Two-way ANOVA found that the drug (cocaine vs saline; F(1,26) = 7.75, p <
0.05) and intracranial infusion (BDNF vs PBS; F(1,26) = 21.45, p < 0.001) had a
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significant main effect on pGluN2B (Y1472) expression, (Fig. 3.3C), but there
was no interaction between drug and infusion (F(1,26)=0.60, p=0.44). SNK multiple
comparison tests revealed that cocaine SA caused a profound reduction in
pGluN2B (Y1472) expression in the dmPFC of PBS-infused rats compared to
yoked-saline treated rats infused with PBS (S-P vs C-P, p<0.05) and that BDNF
infusion not only prevented this decrease in cocaine SA rats (C-P vs C-B, p<0.01)
but augmented the level of pGluN2B (Y1472) in yoked-saline-treated rats (S-P vs
S-B, p<0.05). One way ANOVA found that the expression levels of tERK
(F(3,25)=1.85, p=0.16), tGluN2A (F(3,26)=2.44, p=0.09) and tGluN2B (F(3,26) =0.79,
p=0.51)

were not significantly different among the four experimental groups

when normalized to the calnexin loading control (data not shown).
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Figure 3.3. The effect of BDNF on the
cocaine-induced reduction of pERK,
pGluN2A (Y1325) and pGluN2B (Y1472)
level, 2 hr after intra-dmPFC infusion. In
Experiment 4, (A) pERK, (B) pGluN2A
(Y1325), and (C) pGluN2B (Y1472) levels
were significantly decreased in the cocaine
SA (C-P) group compared to the yokedsaline group (#p<0.05). BDNF increased (A)
pERK, (B) pGluN2A (Y1325), and (C)
pGluN2B (Y1472) levels in the yoked-saline
group (S-B) vs. the yoked-saline-PBS (S-P)
group (*p<0.05, **p<0.01). BDNF prevented
the decrease in (A) pERK, (B) pGluN2A
(Y1325), and (C) pGluN2B (Y1472) levels in
the cocaine SA groups (@p<0.05, @@p<0.01).
The bar graphs indicate the mean ± SEM.
S=Yoked-Sal, C=Cocaine SA, P=PBS,
B=BDNF (n=5-9/group).

Experiment 5: Activity of GluN2A subunitcontaining NMDA receptors in the dmPFC
is required for the effect of BDNF on
pERK and pGluN2A but not pGluN2B
level.
In Experiment 5, all rats were pretreated with
the GluN2A-selective antagonist, TCN-201,
20 min before infusion of BDNF or PBS into
the dmPFC of rats with a cocaine SA or
yoked-saline history and then decapitated 2 hr after infusion to investigate the
involvement of GluN2A subunit-containing NMDA receptor activity on the ability
of BDNF to prevent cocaine SA-mediated reduction in phospho-protein level in
the dmPFC (see Fig. 3.4B). A two-way ANOVA found that TCN-201, had no
effect on the ability of cocaine to decrease pERK levels in the dmPFC; there was
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still a significant main effect of cocaine (cocaine vs saline; F(1,25)=100.90, p<0.001;
Fig. 9A). However, TCN-201 prevented the ability of BDNF to reverse the
cocaine-induced decrease in P-ERK levels; there was no significant main effect
of intracranial infusion (BDNF vs PBS) on pERK (F(1,25)=0.17, p=0.68; Fig 3D).
SNK multiple comparison tests found that, in the presence of TCN-201, cocaine
SA caused a profound reduction in pERK level in the dmPFC of PBS-infused rats
compared to yoked-saline treated rats infused with PBS (S-P vs C-P, p<0.001)
and that TCN-201 effectively blocked BDNF’s ability to increase pERK level in
both yoked-saline treated rats infused with PBS (S-P vs S-B; p>0.05) and
cocaine SA rats infused with PBS (C-P vs C-B; p>0.05), suggesting GluN2A
subunit-containing NMDAR activity is essential for BDNF-mediated pERK level.
Similarly, a two-way ANOVA found that TCN-201 did not prevent the
significant main effect of drug (cocaine vs saline; F(1,25)=322.52 , p<0.001) on
pGluN2A (Y1325) level (Fig. 3.4B). However, TCN-201 prevented the ability of
BDNF to reverse the cocaine-induced decrease in pGluN2A levels; there was no
significant main effect of intracranial infusion (BDNF vs PBS) on pGluN2A levels
(F(1,25)=0.20, p=0.66). SNK multiple comparison tests found that in the presence
of TCN-201, pGluN2A level was significantly suppressed in the PBS-infused
cocaine SA group compared to the PBS-infused yoked-saline group (S-P vs C-P,
p <0.001) and that TCN-201 infusion blocked the ability of the BDNF to increase
pGluN2A level compared to the PBS-infused rats in both yoked-saline (S-P vs SB; p>0.05) and cocaine SA groups (C-P vs C-B; p>0.05), suggesting GluN2A
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subunit-containing NMDARs activity is essential for BDNF-mediated pGluN2A
level.
To confirm the specificity of TCN-201 on GluN2A subunit-containing
NMDARs, the effect of TCN-201 on pGluN2B (Y1472) level was investigated.
Two-way ANOVA found that when TCN-201 was infused before BDNF or PBS
(Fig. 3.4C), the drug (cocaine vs saline; F(1,25)=17.49, p<0.001) and the
intracranial infusion (BDNF vs PBS; F(1,25)=54.24, p<0.001) had a significant main
effect on pGluN2B (Y1472) but there was no interaction between the drug and
the intracranial infusion (F(1,25)=3.59, p=0.07). SNK multiple comparison tests
found that, in the presence of TCN-201, cocaine SA caused a profound reduction
in pGluN2B (Y1472) level in the dmPFC of PBS-infused rats compared to yokedsaline treated rats infused with PBS (S-P vs C-P, p<0.001) and that BDNF
infusion not only prevented this decrease in cocaine SA rats (C-P vs C-B, p<0.01)
but augmented the level of pGluN2B (Y1472) in yoked-saline-treated rats (S-P vs
S-B, p<0.001). As TCN-201 pretreatment before BDNF did not inhibit the ability
of BDNF to enhance pGluN2B level in both yoked-saline and cocaine SA groups,
this suggest the dose of TCN-201 used in the current study selectively blocked
GluN2A subunit-containing NMDARs but not GluN2B subunit-containing
NMDARs.
A one way ANOVA found that, in the presence of TCN-201, the level of
tERK

(F(3,25)=2.70,

p=0.07),

tGluN2A

(F(3,25)=2.45,

p=0.09)

or

tGluN2B

(F(3,25)=2.12, p=0.12) was not significantly different among experimental groups.
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To confirm whether TCN-201 infusion into the dmPFC affected the basal level of
pERK, pGluN2A (Y1325), or pGluN2B (Y1472) level, yoked saline-treated rats
infused with PBS from experiment 4 were compared to yoked saline-treated rats
infused with TCN-201 before PBS from experiment 5. An unpaired t-test found
that there was no significant difference between these groups for pERK (t10=0.27,
p=0.79), pGluN2A (t10= 1.42, p=0.19), and pGluN2B (t10=1.26, p=0.24),
respectively.
Figure 3.4. The effect of BDNF in the
presence of TCN-201 on the cocaineinduced reduction of pERK, pGluN2A
(Y1325) and pGluN2B (Y1472) levels, 2 hr
after intra-dmPFC infusion. In Experiment 5,
intra-dmPFC TCN-201 prevented the ability of
BDNF to increase (D) pERK and, (E)
pGluN2A (Y1325), but not (F) pGluN2B
(Y1472) levels in the dmPFC of yoked-saline
rats. TCN-201 did not prevent the ability of
cocaine SA to decrease (D) pERK, (E)
pGluN2A (Y1325), and (F) pGluN2B (Y1472)
levels in the dmPFC vs. the yoked-saline
group (###p<0.001). TCN-201 reversed the
ability of BDNF to prevent the cocaine SA–
induced decrease in (D) pERK and, (E)
pGluN2A (Y1325), but not (F) pGluN2B
(Y1472) levels in the dmPFC. The bar graphs
indicate the mean ± SEM. S=Yoked-Sal,
C=Cocaine SA, P=PBS, B=BDNF, T=TCN201 (n=7-8/group).
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Experiment 6: Activity of GluN2B subunit-containing NMDA receptors in
the dmPFC is required for the effect of BDNF on pERK and pGluN2B but
not pGluN2A level
In this experiment, all rats were pretreated with the GluN2B-selective antagonist,
Ro-25-6981, 20 min before infusion of BDNF or PBS into the dmPFC in rats with
a cocaine SA or yoked-saline history and then decapitated 2 hrs after infusions to
check the involvement of GluN2B subunit-containing NMDARs activity in the
ability of BDNF to recover pERK and pGluN2B levels in the dmPFC (see Fig.
3.1C). A two-way ANOVA found that Ro-25-6981, had no effect on the ability of
cocaine to decrease P-ERK levels in the dmPFC; there was still a significant
main effect of cocaine (cocaine vs saline; F(1,22)=11.12, p<0.01; Fig. 3.5A).
However, Ro-25-6981 prevented the ability of BDNF to reverse the cocaineinduced decrease in P-ERK levels; there was no significant main effect of
intracranial infusion (BDNF vs PBS) on pERK (F(1,22)=1.05, p=0.32). SNK multiple
comparison tests found that in the presence of Ro-25-6981 cocaine SA caused a
profound reduction in pERK level in the dmPFC of PBS-infused rats compared to
yoked-saline treated rats infused with PBS (S-P vs C-P, p<0.01) and that Ro-256981 effectively blocked BDNF’s ability to increase pERK level in both yokedsaline treated rats infused with PBS (S-P vs S-B; p>0.05) and cocaine SA rats
infused with PBS (C-P vs C-B; p>0.05), suggesting GluN2B subunit-containing
NMDARs activity is essential for BDNF-mediated pERK up-regulation.
Similarly, a two-way ANOVA found that Ro-25-6981 did not prevent the
significant main effect of drug (cocaine vs saline; F(1,22)= 15.31, p<0.01)

on

pGluN2B (Y1472) level (Fig. 3.5B). However, Ro-25-6981 prevented the ability of
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BDNF to reverse the cocaine-induced decrease in pGluN2B levels; there was no
significant main effect of intracranial infusion (BDNF vs PBS) on pGluN2B levels
(F(1,22)= 0.76, p=0.39). SNK multiple comparison tests found that in the presence
of Ro-25-6981, pGluN2B level was significantly suppressed in the PBS-infused
cocaine SA group compared to the PBS-infused yoked-saline group (S-P vs C-P,
p <0.01) and that Ro-25-6981 infusion blocked the ability of the BDNF to
increase pGluN2B level compared to the PBS-infused rats in both yoked-saline
(S-P vs S-B; p>0.05) and cocaine SA groups (C-P vs C-B; p>0.05), suggesting
GluN2B subunit-containing NMDARs activity is essential for BDNF-mediated
pGluN2B level.
To confirm the specificity of Ro-25-6981 on GluN2B subunit-containing
NMDARs, the effect of Ro-25-6981 on pGluN2A (Y1325) level was investigated.
Two-way ANOVA found that when TCN-201 was infused before BDNF or PBS
(Fig. 3.5C), the intracranial infusion (BDNF vs PBS; F(1,22)=28.73, p<0.001), but
not the drug (cocaine vs saline; F(1,22) =0.01, p=0.94) had a significant main
effect on pGluN2B (Y1472). SNK multiple comparison tests found that, in the
presence of Ro-25-6981, cocaine SA caused a profound reduction in pGluN2A
(Y1325) level in the dmPFC of PBS-infused rats compared to yoked-saline
treated rats infused with PBS (S-P vs C-P, p<0.05) and that BDNF infusion not
only prevented this decrease in cocaine SA rats (C-P vs C-B, p<0.001) but
augmented the level of pGluN2B (Y1472) in yoked-saline-treated rats (S-P vs SB, p<0.05). As Ro-25-6981 pretreatment before BDNF did not inhibit the ability of
BDNF to enhance pGluN2A level in both yoked-saline and cocaine SA groups,
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this suggest the dose of Ro-25-6981 used in the current study selectively blocked
GluN2B subunit-containing NMDARs but not GluN2A subunit-containing
NMDARs.
A one way ANOVA found that, in the presence of Ro-25-6981, the level of
tERK (F(3,22)=2.05, p=0.14), tGluN2A (F(3,22) =2.21, p=0.12) and tGluN2B (F(3,22)
=2.35, p=0.10) was not significantly different among experimental groups. To
confirm whether Ro-25-6981 infusion into the dmPFC affected the basal level of
pERK, pGluN2A (Y1325), or pGluN2B (Y1472), yoked saline-treated rats infused
with PBS from experiment 4 were compared to yoked saline-treated rats infused
with TCN-201 before PBS from experiment 5. An unpaired t-test found that there
was no significant difference between these groups for pERK (t8= 0.11, p=0.91),
pGluN2A (t8=0.69, p=0.51), and pGluN2B (t8=1.54, p=0.16), respectively (data
not shown).
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Figure 3.5. The effect of BDNF in the
presence of Ro-25-6981 on the
cocaine-induced reduction of pERK,
pGluN2A (Y1325) and pGluN2B (Y1472)
levels, 2 hr after intra-dmPFC infusion.
In Experiment 6, intra-dmPFC Ro-256981 prevented the ability of BDNF to
increase (D) pERK and, (E) pGluN2B
(Y1472), but not (F) pGluN2A (Y1325)
levels in the dmPFC of yoked-saline rats.
Ro-25-6981 did not prevent the ability of
cocaine SA to decrease (D) pERK, (E)
pGluN2A (Y1325), and (F) pGluN2B
(Y1472) levels in the dmPFC vs. the
yoked-saline group (#p,0.05, ##p<0.01).
Representative Western blot images for
each protein are shown above graphs.
The positions and sizes of the protein
molecular weight markers (kDa) are
indicated on the right. The bar graphs
indicate the mean ± SEM. S=Yoked-Sal,
C= Cocaine SA, P=PBS, B=BDNF,
Ro=Ro-25-6981 (n=5-8 per group).

Discussion
Cocaine SA suppressed the level of
pERK, pGluN2A, and pGluN2B in the
dmPFC.
We recapitulated cocaine SA-induced
ERK dephosphorylation in the dmPFC
(Whitfield et al., 2011) and showed
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concurrent suppression of pGluN2A (Y1325) and pGluN2B (Y1472) levels 2 hr
after the last cocaine SA session. Although the mechanisms underlying these
dephosphorylation events are not yet defined, our preliminary evidence points to
the activation of striatal-enriched tyrosine phosphatase (STEP) in the dmPFC 2
hr after the end of cocaine SA (Sun et al., 2013). STEP dephosphorylates and
inactivates ERK and GluN2A/B directly as well as indirectly through
dephosphorylation and inactivation of SFKs (Paul et al., 2003; Pulido et al., 1998;
Nguyen et al., 2002; Iwasaki et al., 1998; Huang and McNamara, 2010). STEPmediated dephosphorylation of GluN2B at Tyr1472 induces endocytosis (Snyder
et al., 2005), leading to the inhibition of NMDAR-mediated ERK phosphorylation
in cortical neuronal cultures (Braithwaite et al., 2006). The Y1325 residue of
GluN2A is located within the C-terminal domain (Zheng et al., 1998) and
truncation of the GluN2A subunit lacking the C-terminal domain decreases the
basal level of ERK2 activity (Moody et al., 2011). Suppression of pERK, pGluN2A
(Y1325) and pGluN2B (Y1472) levels in the dmPFC within 2 hr of the end of
cocaine SA suggests a profound cocaine-mediated hypofunction of dmPFC. This
discovery is consistent with reduced basal activity of the dmPFC (Sun and Rebec,
2006) and reduced BDNF and immediate early gene mRNA levels within 24 hr
after 10 days of cocaine SA (McGinty et al., 2010).
Cocaine SA-induced reduction of pERK, pGluN2A, or pGluN2B was
not associated with a reduction in the total levels of these proteins 2 hr after the
last session of cocaine SA in this study, suggesting that the tyrosine
dephosphorylation and reduced functional impact of both GluN2 subunits and
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ERK, but not state-independent total protein expression, are critical for triggering
subsequent cocaine-seeking. Similarly, SFK-mediated tyrosine phosphorylation
of synaptic GluN2A did not affect the total GluN1 and GluN2A expression in adult
rat hippocampal slices (Goebel-Goody et al., 2009). However, previous studies
have reported that a decrease in total GluN1 and GluN2B as well as NMDAR
binding in the dmPFC occurs during early withdrawal from short access cocaine
SA (Ben-Shahar et al., 2007; Sun et al., 2013).
BDNF infusion into the dmPFC prevents cocaine-mediated dephosphorylation
events.
In the current study, the intra-dmPFC BDNF infusion immediately after the last
session of cocaine SA normalized a cocaine-mediated reduction in pGluN2A
(Y1325) and pGluN2B (Y1472). BDNF also prevented the cocaine-induced
decrease in the levels of pERK previously reported to be mediated by TrkB
(McGinty

et

al.,

2010;

Whitfield

et

al.,

2011).

BDNF-TrkB

signaling

phosphorylates and activates ERK and GluN2A/B directly or indirectly through
phosphorylation and activation of SFKs. BDNF stimulates the association of TrkB
with Src or Fyn, a member of SFK, leading to SFKs activation and subsequent
activation of TrkB signaling including ERK (Iwasaki et al., 1998; Huang and
McNamara, 2010; Narisawa-Saito et al., 1999). SFKs phosphorylate GluN2A
(Y1325), leading to potentiation of NMDA-stimulated whole cell currents
(Taniguchi et al., 2009). SFKs also phosphorylate GluN2B (Y1472), resulting in
an increase in GluN2B synaptic expression (Nakazawa et al., 2001; Cheung and
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Gurd, 2001; Goebel-Goody et al., 2009) and surface expression (Gao and Wolf,
2008).
In the present study, TCN-201 pretreatment before BDNF was effective in
inhibiting the BDNF-mediated increase in pERK and pGluN2A, but not pGluN2B
levels, whereas Ro-25-6981 blocked BDNF-mediated up-regulations of pERK
and pGluN2B, but not pGluN2A. As the activity of NMDARs is required for the
association between Fyn and GluN2A subunits in rat hippocampus (Hou et al.,
2002), the results of the present study suggest that the dose of TCN-201 and Ro25-6981 used in the current study is selective for GluN2A and Glu2B,
respectively, and that both GluN2A-contatining NMDARs and GluN2B-contatining
NMDARs are essential for the BDNF-mediated pERK augmentation. The
inhibitory effect of TCN-201 and ifenprodil (Ro-25-6981 is a derivative of
ifenprodil) on GluN1/GluN2A and GluN1/GluN2B diheteromers of NMDARs is
much higher than their inhibitory effect on GluN1/GluN2A/GluN2B triheteromers
of NMDARs (Hansen et al., 2014). Therefore, BDNF-mediated upregulation of
pERK, pGluN2A and pGluN2B is likely to occur through GluN1/GluN2A
diheteromers or GluN1/GluN2B diheteromers, not triheteromers.
Stimulation of NMDARs has opposite effects on ERK activity depending
on their relative locations at the synapse. Synaptic NMDAR activity mediates
ERK activation but activation of extrasynaptic NMDARs induces ERK inactivation
(Ivanov et al., 2006) and BDNF reverses the extrasynaptic NMDAR-mediated
ERK inactivation (Mulholland et al., 2008). TrkB receptors are localized in
postsynaptic densities (PSD) of excitatory glutamatergic synapses in the adult rat
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cerebral cortex (Aoki et al., 2000) and the co-localization between the TrkB and
GluN1 on the cellular surface is increased at glutamatergic synapses during
development in dissociated cultures of cortical neurons (Gomes et al., 2006). The
SFKs, Fyn and Src, are expressed higher in synaptic regions than in
extrasynaptic regions in adult rat hippocampal slices (Goebel-Goody et al., 2009)
and binding of SFKs to PSD through the SH2-domain of SFK is required for the
tyrosine phosphorylation of GluN2A and GluN2B by Fyn and Src (Cheung and
Gurd, 2001). PSD-95, also known as SAP-90 (synapse-associated protein 90)
(Kornau et al., 1995), a synaptic scaffolding protein highly expressed in the PSD
(Cho et al., 1992) mediates the association of GluN2A with Fyn/Src and
facilitates Fyn/Src-mediated tyrosine phosphorylation of GluN2A (Tezuka et al.,
1999; Ma and Zhang, 2003; Hou et al., 2003; Chen et al., 2003) Furthermore,
inhibition of SFK decreases the tyrosine phosphorylation of GluN2A in synaptic
but not extrasynaptic regions in adult rat hippocampal slices, and BDNF
enhances tyrosine phosphorylation of GluN2B in rat cortical PSD fractions (Lin et
al., 1998; Goebel-Goody et al., 2009). Together, these data suggest that
GluN2A-containing NMDARs and GluN2B-containing NMDARs, both of which
are

located

at

synaptic

regions,

may

underlie

BDNF-mediated

ERK

phosphorylation and activation through SFKs.
In the present study, TCN-201 or Ro-25-6981 infusion without BDNF did
not affect the levels of pERK, pGluN2A, and pGluN2B in yoked-saline rats
compared to vehicle-infused rats (S-P vs T/S-P; S-P vs Ro/S-P), indicating that
the TCN-201 or Ro-25-6981 treatment had no effect on basal phosphoprotein
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levels. NMDAR activity is highly inhibited under normal neuronal activity because
the NMDAR channel is blocked by magnesium. Therefore, TCN-201 or Ro-256981 under basal conditions without BDNF would have no effect on GluN2A- or
GluN2B-containing NMDAR activity or on tyrosine phosphorylation of GluN2
subunits targeted by SFK because the activity of NMDARs is required for the
association between SFK and GluN2 subunits, as demonstrated in rat
hippocampus (Hou et al., 2002). Further, it is likely that TCN-201 or Ro-25-6981
infusion in the absence of BDNF did not alter the cocaine-induced reductions in
pGluN2A and pGluN2B levels compared to vehicle-infused rats (D-P vs T-P; P-P
vs Ro-P) because cocaine SA decreased the phosphorylation state of these
receptors. However, our results show that the doses of TCN-201 and Ro-256981 used in the current study were effective because they reversed BDNF’s
ability to restore pGluN2B and pGluN2A levels. Therefore, neither TCN-201 nor
Ro-25-6981 infusion had an effect on the phosphorylation state of GluN2A- or
GluN2B-containing NMDARs in the cocaine SA group in the absence of BDNF
and, likewise, exerted no significant effect on cocaine-seeking.
In contrast, in the present study BDNF infusion into the dmPFC increased
phosphorylation of GluN2A and GluN2B at SFK target sites compared to PBSinfused rats in both yoked-saline and cocaine SA groups and effectively
suppressed cocaine-seeking in rats with a cocaine SA history. As discussed
above, functional activity of NMDARs is likely to be low in both yoked-saline and
cocaine SA groups due to voltage-sensitive Mg2+ block and the activity of
NMDARs is required for the association between SFK and GluN2 subunits (Hou
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et al., 2002). Therefore, the current finding of BDNF-mediated phosphorylation of
GluN2A and GluN2B at SFK target sites is surprising. However, in adult cocainenaïve rats, BDNF infusion into the rat NAc core increases cell surface expression
of the GluA1 subunit of AMPA receptors in an ERK- or protein synthesisdependent manner within 30 min post-injection (Li and Wolf, 2011). This
suggests that intra-dmPFC BDNF could effectively remove the magnesium block
from NMDARs in the dmPFC within 2hr of its infusion by increasing functional
AMPA receptors on the cellular surface of the dmPFC, allowing interaction
between SFK and GluN2 subunits, which results in phosphorylation of GluN2A
and GluN2B at SFK target sites. As the phosphorylation of GluN2A (Y1325) and
GluN2B (Y1472) increases single NMDAR channel activity (Xu et al., 2006)
and/or synaptic (Nakazawa et al., 2001; Cheung and Gurd, 2001; Goebel-Goody
et al., 2009) and surface expression (Gao and Wolf, 2008) and as either AMPAR
or NMDAR contributes to the depolarization of spine heads (Grunditz et al.,
2008), the BDNF-mediated phosphorylation of GluN2A and GluN2B would further
activate NMDARs by both the phosphorylation of GluN2A and GluN2B at SFK
sites and the removal of the magnesium block and restoring synaptic activity in
the dmPFC.
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CHAPTER 4

SUMMARY, DISCUSSION, AND FUTURE DIRECTIONS

Summary and Significance
New signaling cascades underlying the suppressive effect of intra-dmPFC BDNF
on cocaine seeking in rats with a cocaine SA history have been discovered. In
this dissertation I showed that two hr after the last session of cocaine SA, pERK,
pGluN2A (Y1325) and pGluN2B (Y1472) levels in the dmPFC were decreased.
BDNF infusion into the dmPFC immediately following the last session of cocaine
SA prevented this reduction of phospho-proteins, suggesting that intra-dmPFC
BDNF ameliorates cocaine SA-induced hypofunction in the dmPFC during early
withdrawal from cocaine. Inhibition of GluN2A-containing NMDARs in the dmPFC
with TCN-201 blocked the BDNF-mediated increase in pERK and pGluN2A
(Y1325), but not pGluN2B (Y1472), and blockade of GluN2B-containing
NMDARs in the dmPFC with Ro-25-6981 suppressed BDNF-mediated elevation
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of pERK and pGluN2B (Y1472), but not pGluN2A (Y1325). The effective
inhibition of intra-dmPFC BDNF’s suppression of cocaine-seeking either by TCN201 or Ro-25-6981 indicates that either inhibition of GluN2A-containing or
GluN2B-containing NMDARs is enough to block BDNF-induced enhancement of
pERK and BDNF’s suppression of cocaine-seeking. These findings also suggest
that co-activation of GluN2A-containing NMDARs and GluN2B-containing
NMDARs is required for BDNF-induced ERK activation and BDNF’s suppressive
effect on cocaine-seeking because TCN-201 or Ro-25-6981 infusion before
BDNF did not prevent BDNF-mediated pGluN2B or pGluN2A levels, respectively.
However, either drug effectively blocked BDNF’s suppression of cocaine-seeking.
Together, the current body of work suggests that BDNF-mediated co-activation of
both GluN2A-containing NMDA receptors and GluN2B-containing NMDA
receptors underlie ERK activity in the dmPFC, and prevents relapse to cocaineseeking.
These studies provide novel and important findings that enhance our
understanding of the molecular mechanisms underlying the relapse to cocaineseeking. First, the cocaine SA-mediated decrease in GluN2 phosphorylation in
the dmPFC provides new evidence that the dmPFC is hypofunctional during
early withdrawal, leading to subsequent cocaine-seeking. Second, exogenous
BDNF-mediated phosphorylation of both GluN2A and GluN2B in the rat dmPFC
is notable considering that there are few in vivo studies showing the role of the
BDNF/TrkB signaling pathway in the phosphorylation of GluN2 subunits and
subsequent modulation of NMDAR activity. Third, BDNF-mediated activation of
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NMDARs containing GluN2A or GluN2B subunits in the dmPFC is critical to the
enduring ability of BDNF to suppress cocaine-seeking. Fourth, the fact that both
GluN2A-containing and GluN2B-containing NMDARs mediate the BDNF-induced
ERK activation in the dmPFC which underlies the suppressive effect of BDNF on
cocaine-seeking sheds light on GluN2 regulation of NMDARs in the dmPFC as a
potential molecular target linked to cocaine-seeking. Finally, although inhibition of
either GluN2A-containing NMDARs or GluN2B-containing NMDARs is sufficient
to inhibit BDNF-mediated increase in pERK level and BDNF’s suppression of
cocaine-seeking, co-activation of GluN2A-containing NMDARs and GluN2Bcontaining NMDARs is necessary for BDNF-induced ERK activation and BDNF’s
suppressive effect on cocaine-seeking. Given that NMDARs are important
modulators of cocaine-mediated neuroadaptations, a further discussion to
explain plausible reasons why activation of both GluN2A-containing and GluN2Bcontaining NMDARs is required for BDNF’s effect on ERK activity and on
suppression of cocaine-seeking will be provided. Moreover, the homeostatic role
of BDNF in the regulation of synaptic plasticity in the dmPFC linked to the
modulation of presynaptic release of glutamate into the NAc core will be
discussed.
Inhibition of either GluN2A-containing NMDARs or GluN2B-containing
NMDARs blocks BDNF’s suppressive effect on cocaine-seeking in a similar
way
We initially hypothesized that blockade of GluN2A-containing NMDARs or
GluN2B-containing NMDARs would inhibit BDNF’s suppressive effect on
cocaine-seeking differently because of their dissimilar characteristics, but we
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found in the current study that either inhibition of GluN2A-containing NMDARs or
GluN2B-containing NMDARs similarly inhibits BDNF’s suppressive effect on
cocaine-seeking.
GluN2A-containing NMDARs and GluN2B-containing NMDARs have
different ion channel kinetics. GluN2 subunit compositions of NMDARs regulate
the kinetic properties of NMDARs. GluN2A-containing NMDARs have a higher
open probability than GluN2B-containing NMDARs in response to brief
application of glutamate. In contrast, as GluN2B-containing NMDARs open
longer than GluN2A-containing NMDARs, they sustain a greater activation for
longer periods. Together, GluN2A-containing NMDARs show a quicker and
sharper increase in open probability which lasts a shorter time and GluN2Bcontaining NMDARs show a slower increase in opening probability that endures
for longer periods. Theses kinetic properties also affect their responses to
stimulation at different frequencies. Under high frequency tetanic stimulation (100
Hz, a protocol for inducing LTP), GluN2A-containing NMDARs transfer more
current but when stimulated at low frequencies (1Hz, a protocol for inducing LTD)
GluN2B-contatining NMDARs pass more current (Erreger et al., 2005; Vicini et
al., 1998; Cull-Candy et al., 2001). In the dendritic spines of rat CA1 pyramidal
neurons, small-volume spines have more GluN2B-containing NMDARs that
contribute to longer current and more calcium per unit of current than those of
large-volume spines (Sobczyk et al., 2005). Together, this suggests that GluN2Acontaining NMDARs and GluN2B-containing NMDARs contribute to ERK activity
to a different degree, because synaptic NMDAR-mediated Ca2+ influx induces
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phosphorylation

of ERK and

CREB in cultured hippocampal

neurons

(Hardingham et al., 2001).
In addition, many previous studies suggest opposite roles of GluN2Acontaining NMDARs and GluN2B-containing NMDARs in ERK activity due to
their different locations relative to the synapse. During development, synaptic
GluN2B-containing NMDARs are replaced by GluN2A-containing NMDARs and
transferred to extrasynaptic regions, leading to predominant expression of
GluN2A-containing NMDARs at the synaptic regions and GluN2B-containing
NMDARs at extrasynaptic regions (Dumas, 2005). Synaptic NMDARs upregulate ERK activity but extrasynaptic NMDARs down-regulate it (Ivanov et al.,
2006). However, a recent study shows that both GluN2A-containing NMDARs
and GluN2B-containing NMDARs are localized in both the synaptic and
extrasynaptic regions (Thomas et al. 2006). Moreover, most studies indicating
the discrete localization of GluN2A-containing NMDARs and GluN2B-containing
NMDARs relative to the synapse are derived from primary sensory cortices such
as visual cortex not PFC. In addition, the functional neurotransmission via
GluN2B-containing NMDARs emerges only after the late adolescent period in the
rat medial PFC including the prelimbic and infralimbic regions and this
emergence of GluN2B-mediated neurotransmission is essential for the ventral
hippocampal-induced LTP in the dmPFC of P50–80 mice (Flores-Barrera et al.,
2014). Further, in the telencephalon of mice, phosphorylation of Y1472 GluN2B,
which is associated with the synaptic expression of GluN2B-containing NMDA
receptors (Goebel-Goody et al., 2009), is gradually enhanced during postnatal
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development (P3-P56) (Nakazawa et al., 2001). Together, these results support
our findings in the current study that either inhibition of GluN2A-containing
NMDARs or GluN2B-containing NMDARs is similarly effective to block BDNF’s
suppressive effect on cocaine-seeking.
Activation of both GluN2A-containing NMDARs and GluN2B-containing
NMDARs is required to mediate BDNF’s suppressive effect on cocaineseeking
Although we found in the current study that inhibition of either GluN2A-containing
NMDARs or GluN2B-containing NMDARs is sufficient to block BDNF-mediated
pERK enhancement and BDNF’s suppressive effect on cocaine-seeking,
activation of either GluN2A-containing NMDARs or GluN2B-containing NMDARs
is not enough to mediate BDNF-induced pERK up-regulation and BDNF’s
suppressive effect on cocaine-seeking. Instead, activity of both GluN2Acontaining NMDARs and GluN2B-containing NMDARs is necessary to mediate
BDNF’s effects. In the present study infusion of the GluN2A-selective antagonist,
TCN-201, before BDNF did not prevent BDNF-mediated pGluN2B enhancement,
suggesting that TCN-201 infusion before BDNF did not affect BDNF-induced
enhancement of GluN2B-containing NMDAR function; however, the TCN-201
pretreatment effectively blocked BDNF-induced pERK up-regulation and BDNF’s
suppression of cocaine-seeking. Together, this suggests that activation of
GluN2B-containing NMDARs is not sufficient to mediate BDNF’s effects and that
co-activation of GluN2A-containing NMDARs and GluN2B-containing NMDARs is
required to mediate BDNF’s effects. Similarly, the GluN2B-selective antagonist,
Ro-25-6981, before BDNF did not prevent BDNF-enhanced pGluN2A level;
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however, the Ro-25-6981 pretreatment effectively blocked BDNF-induced pERK
level and BDNF’s suppression of cocaine-seeking, suggesting that activation of
GluN2A-containing NMDARs is not sufficient to mediate BDNF’s effects and that
co-activation of GluN2A-containing NMDARs and GluN2B-containing NMDARs is
required to mediate BDNF’s effects. The requirement of co-activation of GluN2Acontaining NMDARs and GluN2B-containing NMDARs for BDNF’s effects may
be explained by their co-localization in the same pyramidal neurons of dmPFC.
GluN2A and GluN2B are expressed and distributed similarly both at apical
and basal dendrites in layer V neurons in the mPFC of mice (postnatal days 21–
33) (Balsara et al., 2014). In dendritic spines of rat CA1 pyramidal neurons,
small-volume spines contain more GluN2B-containing NMDARs that contribute to
longer current and more calcium per unit of current than those of large-volume
spines (Sobczyk et al., 2005). GluN2A-containing NMDARs are involved in
basolateral amygdala (BLA)-induced LTP whereas GluN2B-containing NMDARs
are essential for ventral hippocampal-induced LTP in the dmPFC of P50–80 mice
(Flores-Barrera et al., 2014). Together, this indicates that both GluN2Acontaining NMDARs and GluN2B-containing NMDARs may be located in the
same pyramidal neurons of dmPFC and that while GluN2A-containing NMDARs
may be located preferentially at large-volume spines where glutamatergic
afferents from the ventral hippocampus (vHipp) make synaptic connection,
GluN2B-containing NMDARs may be located preferentially at small-volume
spines where glutamatergic afferents from the BLA make synaptic contact.
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Selective inhibition of neuronal activity in the ventral hippocampus (Rogers
and See, 2007), BLA, or dmPFC (McLaughlin and See, 2003) immediately before
a reinstatement test suppresses cocaine-seeking induced by cocaine-associated
cues. Further, selective inhibition of neuronal activity in the ventral hippocampus
(Lasseter et al., 2010), BLA, or dmPFC (Fuchs et al., 2005) immediately before a
reinstatement test decreases context-induced cocaine-seeking. Together, this
suggests that although inhibition of either BLA or the ventral hippocampus
immediately before a reinstatement test is sufficient to suppress cocaine-seeking,
activation of either BLA or the ventral hippocampus is not enough to mediate
reinstatement of cocaine-seeking. Instead, activity of both BLA and the ventral
hippocampus is necessary to mediate reinstatement of cocaine-seeking. This
also indicates that dmPFC, which receives glutamatergic input from both vHipp
and BLA, may play a functional role as a common gate in the neural circuitry
underlying cocaine-seeking. If we assume that GluN2A-containing NMDARs and
GluN2B-containing NMDARs may be located in the same pyramidal neuron
rather than in different subpopulations of pyramidal neurons of dmPFC, we could
explain better the reason for the requirement of both BLA and ventral
hippocampus activity to mediate reinstatement of cocaine-seeking.
Although GluN2A-contatining NMDARs and GluN2B-contatining NMDARs
may be segregated on different spines of the same pyramidal neurons in dmPFC
that are innervated by discrete glutamatergic from different brain regions, a
convergence of inputs from both BLA and vHipp onto the same pyramidal
neurons of dmPFC may be required to reach a threshold level of intracellular
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Ca2+ concentration that is required for the full and sustained activation of ERK.
This convergence would explain why co-activation of GluN2A-containing
NMDARs and GluN2B-containing NMDARs are required for the effects of BDNF
on pERK enhancement and on suppression of cocaine-seeking.
The relatively small differences in Ca2+ influx via GluN2A-containing
NMDARs and/or GluN2B-containing NMDARs could produce dramatic changes
in downstream signaling of the Ca2+/Calmodulin (CaM) complex. Due to the
limited amount of Ca2+/CaM complex, many of its targets compete for binding to
Ca2+/CaM. CaMKII and calcineurin (PP2B) are prominent targets of the Ca2+/CaM
complex (Kennedy et al., 2005). Modulation of CaMKII activity depending on the
intracellular level of Ca2+ could explain why co-activation of GluN2A-containing
and GluN2B-containing NMDARs is required for the effects of BDNF on pERK
up-regulation

and

on

suppression

of

cocaine-seeking.

BDNF

induces

autophosphorylation of alpha-CaMKII (CaMKIIα) at Thr286 and long-lasting
activation of it (Blanquet et al., 2003). CaMKII inhibition blocks group I
metabotropic glutamate receptor (mGluR)-mediated increase in pERK and
pCREB in the rat dorsal striatum (Choe and Wang, 2001), and CaMKII underlies
nicotine-induced ERK phosphorylation in cultured mouse cortical neurons
(Steiner et al., 2007). Together, this suggests that CaMKII activity may underlie
BDNF-induced pERK enhancement in the dmPFC via NMDAR containing
GluN2A or GluN2B. Under the relatively low level of intracellular Ca2+, CaMKII
activity is dependent on Ca2+/CaM complex binding to it; however, under
relatively

greater

amounts

of

intracellular
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Ca2+,

CaMKII

undergoes

autophosphorylation at Thr286, which renders CaMKII long-lasting Ca2+/CaMindependent (autonomous) activity without altering its maximal Ca2+/CaMstimulated activity (Miller and Kennedy, 1986; Hudmon and Schulma, 2002).
Together, activation of either GluN2A-containing NMDAR or GluN2B-containing
NMDAR would not be enough to induce autophosphorylation of CaMKII, however,
co-activation of GluN2A-containing NMDAR and GluN2B-containing NMDAR by
intra-dmPFC BDNF could amplify Ca2+ influx, leading to the autophosphorylation
and long-lasting activation of CaMKII and subsequently sustained ERK activity in
the dmPFC.
Activation of PP2B, another prominent target of the Ca2+/CaM complex, is
linked to dephosphorylation and activation of STEP (Paul et al., 2003). STEP is a
protein phosphatase which dephosphorylates and inactivates ERK and
GluN2A/B directly as well as indirectly through dephosphorylation and
inactivation of SFKs (Paul et al., 2003; Pulido et al., 1998; Nguyen et al., 2002;
Iwasaki et al., 1998; Huang and McNamara, 2010). A previous study from our lab
found that STEP is activated in the dmPFC 2 hr after the end of cocaine SA
compared to yoked-saline controls, suggesting STEP may be the phosphatase
responsible for cocaine SA-mediated dephosphorylation of GluN2A, GluN2B and
ERK (Sun et al., 2013). A delayed larger increase in intracellular Ca2+ via
GluN2B-containing NMDARs is required to mediate STEP dephosphorylation
and activation as well as ERK inactivation in primary neuronal cultures (Paul and
Connor, 2010). However, in the present study we showed that two hr after the
last session of cocaine SA, pERK, pGluN2A (Y1325) and pGluN2B (Y1472)
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levels in the dmPFC were decreased, suggesting NMDAR hypofunction.
Together, during early withdrawal from cocaine SA, STEP and Ca2+/CaMdependent CaMKII activity could be mediated but induction of CaMKII
autophosphorylation would fail because of the relatively low concentration of
intracellular Ca2+ due to NMDAR hypofunction. Under this condition, the effect of
STEP on ERK dephosphorylation would overcome the effect of CaMKII on ERK
phosphorylation, leading to cocaine SA-induced ERK shut-off through STEP. In
contrast, BDNF-induced phosphorylation of both GluN2A and GluN2B may
induce a local, relatively high concentration of Ca2+, sites with a restricted high
Ca2+ concentration in the immediate vicinity of synaptic NMDARs, which would
be sufficient for the induction of autophosphorylation and autonomous activity of
CaMKII and STEP activity. In this condition, the sustained effect of CaMKII on
ERK

phosphorylation

would

surpass

the

effect

of

STEP

on

ERK

dephosphorylation, which may contribute to BDNF-mediated ERK activity.
However,

activation

of either GluN2A-contatining or

GluN2B-contatining

NMDARs may not be enough to induce CaMKII autophosphorylation due to
relatively lower Ca2+ influx via either of them compared to the Ca2+ influx through
both of them.
While weak presynaptic stimulation of presynaptic neurons leads to
accumulation of intracellular Ca2+ within single postsynaptic spines not in the
dendritic shaft, stronger stimulation increases intracellular Ca2+ levels both in a
single postsynaptic spine and the parent dendrite in an NMDAR-dependent way
(Müller and Connor, 1991), which can diffuse and increase intracellular
71

concentration of Ca2+ further in the soma. The increase also would help to
remove the magnesium block of NMDARs by increasing neuronal activity, which
further enhances functional NMDAR activity and subsequent Ca2+ influx via
NMDAR. Therefore, intracellular concentration of Ca2+ in the soma would be
amplified and prolonged by the co-activation of GluN2A-containing NMDARs and
GluN2B-containing

NMDARs.

Together,

BDNF-mediated

co-activation

of

GluN2A-containing NMDARs and GluN2B-containing NMDARs would be
required to effectively remove the magnesium block of NMDARs by increasing
synaptic neuronal activity, which further promotes subsequent BDNF-mediated
NMDAR activity followed by ERK activation. As both BDNF and NMDARs are
important modulators of synaptic plasticity, intra-dmPFC BDNF-induced ERK
activity in the dmPFC through both GluN2A- and GluN2B-containing NMDARs
may contribute to recovery of cocaine SA-mediated hypofrontality. GluN2Bcontatining NMDAR activity is required for the sustained ERK1/2 phosphorylation,
which is linked to enhancement of synaptic AMPAR expression as well as spine
volume (El Gaamouch et al., 2012), thus supporting this idea.
BDNF-mediated recovery of neuronal activity in the dmPFC leads to
normalization of glutamatergic neurotransmission in the PFC-NAc pathway
associated with suppression of cocaine-seeking
Dopamine modulates rat PFC long-term plasticity, LTP and LTD (Otani et al.,
2003). D1 receptors in the rat PFC induce LTP at hippocampal-prefrontal
synapses (Gurden et al., 2000). Together, as cocaine acts as an indirect
dopamine agonist in the dmPFC, these results suggest that cocaine may induce
long-lasting synaptic plasticity in the dmPFC via DA receptors and this cocaine72

mediated dysregulation of neural plasticity in the dmPFC may also affect synaptic
plasticity in the NAc core through modulation of the dmPFC-NAc pathway. During
withdrawal from cocaine SA, the ability to mediate LTP and LTD is compromised
in the rat NAc core (Moussawi et al., 2009), which supports this idea.
Cocaine addiction is characterized by the addict’s inability to adapt
behavior in response to new stimuli, which is associated with persistent cocaineseeking after extended periods of withdrawal or abstinence. Maladaptation in
critical brain regions, such as dmPFC and NAc core, may underlie enduring
relapse to cocaine-seeking. The present study showed that intra-dmPFC BDNF
blocks cocaine SA-mediated dephosphorylation of ERK, GluN2A (Y1325) and
GluN2B (Y1472) in the dmPFC during early withdrawal. This result is consistent
with a previous study from our lab (Whitfield et al., 2011) showing that BDNF
prevented cocaine-SA induced CREB dephosphorylation in the dmPFC during
early withdrawal, suggesting that intra-dmPFC BDNF rescues cocaine SAinduced disruption of normal neuronal activity within the rat dmPFC. Rats with a
cocaine SA history show reduced basal activity of the dmPFC (Sun and Rebec,
2006) and cocaine addicts also show decreased basal metabolic activity in the
PFC (Bolla et al., 2004; Volkow et al., 1992; Volkow and Fowler, 2000). In the rat
PFC, while a single injection of cocaine enhances BDNF mRNA and protein
expression 24 hr after injection, repeated non-contingent injections of cocaine
decrease BDNF protein expression 2 or 72 h after the last injection (Fumagalli et
al., 2007). Moreover, BDNF and immediate early gene mRNA are also reduced
22 h after the last session of cocaine SA (McGinty et al., 2010), indicating PFC
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hypofunction during early withdrawal from cocaine SA. However, a clinical study
shows that administration of methylphenidate, a drug that has similar
pharmacological effects as cocaine (Volkow et al., 1995), induces PFC
hyperactivity, which is associated with cocaine craving (Volkow and Fowler, 2000)
and a pre-clinical study also shows that cocaine infusion following 2-3 weeks of
cocaine SA induces hyperexcitability in the rat dmPFC (Sun and Rebec, 2006).
Together, these data suggest that a chronic cocaine-mediated reduction in basal
activity of dmPFC may lead to dmPFC hyperexcitability in response to cocaine as
a compensatory mechanism, which results in cocaine craving and seeking in
response to cocaine. Intra-dmPFC BDNF infusion immediately after the last
session of cocaine SA would block this transition of hypofrontality to
hyperexcitability in the dmPFC by reversing hypofrontality during early withdrawal
from cocaine SA. Intra-dmPFC BDNF-mediated SFK or ERK activation may
upreguate AMPAR functions. In cultured rat neocortical neurons, BDNF
enhances the total level of GluR1 or GluR2/3 via SFK (Narisawa-Saito et al.,
1999). In cultured neurons, NMDAR stimulation increases the surface expression
of the GluR1 subunit of AMPARs through ERK activation (Kim et al., 2005). In
adult drug-naïve rats, BDNF infusion into the rat NAc core increases cell surface
expression of GluA1 in an ERK- or protein synthesis-dependent manner 30 min
post-injection but not 3h or 24h post-injection. As the surface level of GluA2 or
GluA3 is not altered by this BDNF infusion, this result suggests that BDNF
upregulates calcium-permeable AMPA receptors (CP-AMPARs) on the cell
surface in the rat NAc core (Li and Wolf, 2011). Taken together, BDNF-induced
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recovery of phosphoprotein levels in the dmPFC may normalize PFC neuronal
excitability during early withdrawal, which prevents cocaine SA-mediated
disruptions in the normal activity of dmPFC during extended withdrawal from
cocaine SA.
It is possible that intra-dmPFC BDNF-mediated recovery of hypofrontality
alters glutamatergic transmission in the dmPFC-NAc core pathway. BDNFmediated normalization of neuronal excitablilty in the dmPFC would also
normalize the dysfunctional synaptic plasticity in the NAc core induced by
cocaine SA. Cocaine-seeking after cocaine SA mediated by context-cue or
discrete cues increases expression of activity-regulated genes, including c-fos
and bdnf in the dmPFC (Ciccocioppo et al., 2001; Hearing et al., 2008), indicating
an increase in neuronal activity in the dmPFC by cocaine-associated cues.
Further, tetrodotoxin (TTX) infusion-mediated inactivation of dmPFC immediately
before a reinstatement test suppresses discrete cue-mediated cocaine-seeking
(McLaughlin and See, 2003), suggesting neuronal activity elicited by discrete
cues in the dmPFC underlies cocaine-seeking. Furthermore, infusion of
dopamine or cocaine into dmPFC induces cocaine-seeking after cocaine SA by
increasing AMPAR-mediated glutamate transmission in the nucleus accumbens
(McFarland and Kalivas 2001; Park et al. 2002) and inhibition of dmPFC
neuronal activity immediately before reinstatement suppresses cocaine-prime
induced cocaine-seeking and the associated increase in extracellular glutamate
levels in the NAc core of rats with a cocaine SA history (McFarland et al., 2003).
Intra-dmPFC infusion of BDNF normalizes a cocaine SA-mediated decrease in
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the basal level of extracelluar glutamate and a cocaine prime-induced increase in
extracelluar glutamate level in NAc core of rats (Berglind et al., 2009), which is
associated

with

suppression

of

cocaine-seeking.

The

BDNF-induced

normalization of cocaine-mediated suppression in the basal level of extracellular
glutamate may recover cocaine-induced reduction of presynaptic mGluR2/3
autoreceptor activity (Moran et al., 2005) in the NAc, core, which would inhibit
further release of glutamate into the NAc core by a cocaine priming injection.
Together, these studies support the idea that BDNF-induced phosphorylation of
both GluN2A and GluN2B in the dmPFC may prevent hypofrontality during early
withdrawal, which may normalize extracellular glutamate tone in the NAc core by
increasing glutamate release into the NAc core. Recovery of extracellular
glutamate levels in the NAc core would further prevent excessive glutamate
release into the NAc core induced by cocaine-associated cues or cocaine itself,
leading to suppression of cocaine-seeking.
Collectively, cocaine SA may reduce BDNF expression and its subsequent
downstream signaling activity in the dmPFC during early withdrawal, resulting in
hypofrontality. Intra-dmPFC BDNF may prevent cocaine- or cocaine-associated
cue-mediated

PFC

hyperexcitability

as

well

as

subsequent

abnormal

glutamatergic neurotransmission in the dmPFC-NAc core pathway that is
associated with cocaine craving and seeking.
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Figure 4.1. Proposed model of the crosstalk between TrkB and NMDARs
leading to ERK activation in the pyramidal neurons of the dmPFC. During
early withdrawal, basal neuronal activity of the dmPFC is highly suppressed and
under the condition Mg2+ blocker of NMDAR blocks NMDAR, inhibiting Ca2+ influx
through NMDAR. Subsequently, concentration of intracellular Ca2+ is very low,
resulting in binding of Ca2+/CaM complex to PP2B and CaMKIIα, leading to
STEP dephosphorylation and activation and Ca2+/CaM-dependent CaMKIIα
activity. Active STEP directly or indirectly dephosphorylates and inactivates ERK,
SFK, and GluN2A/2B, all of which result in inhibition of ERK phosphorylation and
CaMKIIα-mediated ERK phosphorylation does not overcome STEP-induced ERK
dephosphorylation. BDNF binding to TrkB induces autophosphorylation of TrkB
at Y705/Y706, leading to TrkB kinase activation and subsequent phosphorylation
at Y515. This phosphorylation at Y515 induces activation of TrkB downstream
signaling pathway of ERK. Autophosphorylated and activated TrkB also
phosphorylates and activates SFK and active SFK promotes phosphorylation of
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TrkB at Y705/Y706, leading to further activation of TrkB-ERK signlaing. SFK also
phosphorylates GluN2A and GluN2B, which results in the upregulation of
synaptic GluN2A-containing NMDARs and GluN2B-containing NMDARs,
respectively. As BDNF-mediated ERK signaling also enhances basal neuronal
activity of the dmPFC via AMPAR insertion into the cellular surface, now Mg2+
blocker of NMDAR is released. Both SFK-mediated phosphorylation of NMDAR
at GluN2A/GluN2B and Mg2+ block release from NMDAR leads to the functional
NMDAR activation and subsequent increase in Ca2+ influx through NMDAR,
which leads to enhancement of the intracellular Ca2+ level. Under the condition,
CaMKIIα is autophosphorylated, leading to Ca2+/CaM-independent CaMKIIα
activity. Long-lasting CaMKIIα activation induces sustained ERK activation and
surpasses STEP-mediated ERK dephosphorylation and inactivation. In this way,
CaMKIIα activation via synaptic NMDAR is positively linked to ERK activity.

Future Directions
Although our findings of BDNF-mediated co-activation of GluN2A- and GluN2Bcontaining NMDARs have

expanded our

knowledge

of

the

molecular

mechanisms by which BDNF induces ERK activation in the dmPFC associated
with cocaine-seeking, additional studies including investigation of the roles of
CaMKIIα, STEP and SFK in the BDNF’s effect would further advance our
understating of the molecular mechanisms underlying BDNF’s effect in the
cortico-accumbens glutamate afferents. Those additional studies are as follows:
1) Infuse the SFK inhibitor PP2 before BDNF into the dmPFC to examine
whether SFK inhibition blocks the ability of BDNF to normalize dmPFC
phospho-proteins and suppress cocaine seeking.
2) Infuse the CaMKII selective inhibitor KN-93 before BDNF into the dmPFC
to examine whether CaMKII inhibition blocks the ability of BDNF to
normalize dmPFC pERK level and suppress cocaine seeking.
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3) Infuse TAT-STEP WT fusion protein into the dmPFC before BDNF to
assess whether increasing STEP level will block the ability of BDNF to
normalize dmPFC phospho-proteins and suppress cocaine seeking.
4) Quantify cocaine SA or intra-dmPFC BDNF-induced changes in
expression of GluN2A- and GluN2B-containing NMDARs in terms of
cellular surface versus intracellular receptors using biotin cell surface
labeling. This would clarify whether cocaine or BDNF-mediated alteration
in tyrosine phosphorylation of GluN2 subunits would affect their surface
membrane expression.
5) Quantify cocaine SA or intra-dmPFC BDNF-induced changes in
expression of GluN2A- and GluN2B-containing NMDARs in terms of
extrasynaptic versus synaptic regions using Triton X-100 extraction as
synaptic membranes are insoluble in Triton-X 100. This would clarify
whether cocaine or BDNF-mediated alteration in tyrosine phosphorylation
of GluN2 subunits would affect their synaptic and extrasynaptic
expression.
6) Examine whether intra-dmPFC TCN-201 or Ro-25-6981 inhibit the effect
of BDNF to normalize cocaine SA-induced decrease and cocaine primeinduced increase in extracellular glutamate levels in the NAc core using in
vivo no-net flux microdialysis.

79

Significance Statement
The novel findings of BDNF-mediated co-activation of GluN2A- and GluN2Bcontaining NMDARs expand our knowledge of the molecular mechanisms by
which BDNF induces ERK activation in the dmPFC. These studies will impact the
field of cocaine addiction research by improving the understanding of the
underlying molecular mechanisms of BDNF/TrkB signaling in the dmPFC during
early withdrawal that modulate relapse to cocaine-seeking. Understanding how
BDNF normalizes excitatory synaptic transmission in the dmPFC during early
withdrawal will expand the potential molecular targets for the treatment of
cocaine addiction, which would facilitate therapeutic development for cocaine
addicts. Early intervention during early withdrawal from cocaine would be
significantly more advantageous than treatment after prolonged abstinence by
avoiding or reducing additional cocaine-seeking and taking over the course of
treatment. Moreover, early intervention could expand the therapeutic possibilities
available to addicted individuals depending on their phase or severity of addiction.
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